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Abstract 
Physical activity is generally beneficial to maintain good health and prevent diseases. 
Development of some diseases may include epigenetic changes. Epigenetic changes involve 
alterations to the genome without changing the DNA sequence itself. Different factors have been 
found to cause epigenetic changes in our DNA, such as age, gender, lifestyle and environment. 
DNA methylation is an epigenetic change described as the addition of a chemical methyl group 
(CH3) to the DNA. Ordinarily, DNA methylation is naturally occurring and probably harmless, but 
sometimes these changes can alter gene expression and trigger diseases. A recent study 
discovered that exercise could provide an acute reduction in DNA methylation of specific genes, 
but that the methylation reoccurred with time.  
 
In this project we wanted to investigate whether regular high-intensity interval training can 
change the DNA methylation in a more long-lasting state, and whether these changes affect the 
gene expression. Our null hypothesis was that no such exercise-induced changes occur. Healthy 
men (70-75 year old) were randomized into two groups: a control group (n=13) and a high-
intensity interval training (HIIT) group (n=13). Testing was performed in both groups at 
baseline and after eight weeks. The HIIT group performed high-intensity interval training on 
treadmill three days a week for eight weeks, whereas the control group was instructed to live 
normally. To test our hypothesis DNA methylation and gene expression were analyzed in muscle 
tissue from participants. Additionally, specific health factors and possible complications of high-
intensity interval training among elderly were investigated. 
 
Significant differences was detected between the two groups, where the HIIT group increased 
their maximal aerobic capacity, reduced their body mass index and waist circumference, while 
the control group decreased their HDL cholesterol. Inverse relationships were detected between 
the groups regarding their change in DNA methylation of four specific CpG sites, but the 
relationships were not proven significant. No significant differences between the groups were 
observed in changes of gene expression of the CpG sites associated genes MYH1, VDAC2, BNIP3, 
and COX16. However, the results give reasons to believe that an improvement in VO2max can 
affect the naturally occurring changes of DNA methylation in our genome. Still, due to study 
weaknesses, larger and more extensive studies are needed to determine whether high-intensity 
interval training actually changes DNA methylation, and to find out which consequences these 
changes have.   
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Sammendrag  
Fysisk aktivitet er generelt gunstig for å opprettholde en god helse og forebygge sykdommer. I 
de siste årene har vi blitt klar over nye prosesser som kan påvirke arvematerialet vårt og som 
ser ut til å være nært knyttet til sykdomsutvikling. Disse prosessene kalles epigenetiske 
forandringer, og er endringer som skjer i genmaterialet vårt uten å endre selve DNA-sekvensen. 
Slike endringer er som oftest ufarlige, men i visse tilfeller kan de sannsynligvis bidra i 
utviklingen av sykdommer. Flere faktorer, som alder, kjønn, livsstil og miljø, har vist seg å kunne 
påvirke epigenetiske endringer. DNA-metylering er epigenetiske endringer hvor kjemiske 
metylgrupper (CH3) fester seg til DNA-sekvensen. Metyleringen er dynamisk og har vist seg å 
kunne påvirke genekspresjon. Det er viktig å finne ut både hvordan DNA-metylering 
forekommer og hvilke konsekvenser dette har. Nylig viste en studie at én treningsøkt ga spontan 
reduksjon i DNA-metylering av enkelte gener, men at metyleringen økte igjen etter en viss tid.  
 
Gjennom dette prosjektet ville vi å undersøke om regelmessig trening kan endre DNA-
metyleringen av genomet vårt i en langvarig forstand, og om disse endringene kan påvirke 
genekspresjonen. Nullhypotesen vår var at ingen slike endringer oppstår som følge av trening. 
Friske menn i alderen 70-75 år ble randomisert til en kontrollgruppe (n=13) og en 
høyintensitets intervalltrenings (HIIT) gruppe (n=13). Tester ble utført i begge grupper ved 
oppstart og etter åtte uker. HIIT gruppen gjennomførte åtte uker med høyintensitets 
intervalltrening på tredemølle tre ganger i uken, mens kontrollgruppen ble oppfordret til å leve 
som normalt. For å teste hypotesen vår ble DNA-metylering og genekspresjon analysert i 
muskelvev fra deltakerne. I tillegg ble bestemte helsefaktorer målt og eventuelle komplikasjoner 
som følge av høyintensitets intervalltrening av de eldre undersøkt. 
  
Treningsgruppen viste en signifikant økning i maksimal aerob kapasitet, og en signifikant 
reduksjon i BMI og midjemål, mens kontrollgruppen viste en signifikant reduksjon i HDL-
kolesterol. Motsatte endringer ble påvist i gruppene når det gjaldt endringer i DNA-metylering 
av utvalgte CpG-seter. Det vil si at i de CpG-setene hvor DNA-metyleringen ble redusert i HIIT 
gruppen viste en økning kontrollgruppen, og motsatt. Resultatene gir grunn til å tro at en 
forbedring i VO2max kan påvirke de naturlige endringene som skjer i DNA-metyleringen i 
arvematerialet vårt, men endringene ble ikke vist signifikante. Ingen signifikante forskjeller 
vistes mellom gruppene i endring av genekspresjon av MYH1, VDAC2, BNIP3 og COX16, som var 
de de utvalgte CpG-setenes assosierte gener. På grunn av svakheter i studien er det behov for 
mer omfattende studier for å avgjøre om høyintensitets intervalltrening kan endre DNA-
metyleringen i arvematerialet vårt, og for å finne ut hvilke effekter disse endringene har. 
 Sammendrag  
 vi 
  
  
 
ACKNOWLEDGMENTS I 
ABSTRACT III 
SAMMENDRAG V 
1 INTRODUCTION 1 
1.1 AN AGING POPULATION 1 
1.2 PHYSICAL ACTIVITY AND HEALTH 1 
1.3 AEROBIC CAPACITY 1 
1.4 AGING, TRAINABILITY AND THEIR EFFECT ON AEROBIC CAPACITY 2 
1.5 EFFECTS OF EXERCISE ON THE LIPID PROFILE OF CARDIOVASCULAR HEALTH 3 
1.6 EPIGENETICS AND GENE EXPRESSION 3 
1.7 EFFECTS OF DNA METHYLATION ON GENE EXPRESSION 5 
1.8 CAUSES OF CHANGE IN DNA METHYLATION 6 
1.9 THE FUTURE OF EPIGENETIC AND EXERCISE IN RELATION TO HEALTH 6 
1.10 THE RESEARCH HYPOTHESIS 7 
1.11 RESEARCH OBJECTIVES 7 
2 EXPERIMENTAL PROCEDURES AND METHODS 9 
2.1 SUBJECTS 9 
2.1.1 INCLUSION AND EXCLUSION CRITERIA 9 
2.2 SAMPLING PROCEDURE 11 
2.2.1 HEIGHT, WEIGHT, BODY MASS INDEX, BODY FAT AND WAIST CIRCUMFERENCE 13 
2.2.2 BLOOD ANALYSES OF RISK MARKERS OF CARDIOVASCULAR DISEASE 13 
2.2.3 MAXIMAL AEROBIC CAPACITY AND MAXIMAL HEART RATE 13 
2.2.4 MUSCLE BIOPSIES FROM VASTUS LATERALIS 14 
2.3 THE EXERCISE PERIOD 14 
2.3.1 HIGH-INTENSITY INTERVAL TRAINING GROUP 15 
2.3.2 CONTROL GROUP 15 
2.4 WET LABORATORY ANALYSES 15 
2.4.1 DNA METHYLATION ANALYSIS 16 
2.4.2 GENE EXPRESSION ANALYSES 19 
2.5 ETHICS 22 
2.6 BIOBANK 23 
2.7 STATISTICS 23 
  
 
3 RESULTS 25 
3.1 BODY MASS INDEX, BODY FAT AND WAIST CIRCUMFERENCE 25 
3.2 CIRCULATING BLOOD MARKERS OF CARDIOVASCULAR HEALTH 25 
3.3 MAXIMAL AEROBIC CAPACITY 26 
3.4 DNA METHYLATION 28 
3.5 GENE EXPRESSION 29 
3.6 CORRELATION ANALYSES OF CHANGES IN DNA METHYLATION AND CHANGES IN GENE EXPRESSION30 
4 DISCUSSION 31 
4.1 HIGH-INTENSITY INTERVAL TRAINING IN ELDERLY 31 
4.2 POSITIVE HEALTH EFFECTS OF HIGH-INTENSITY INTERVAL TRAINING 32 
4.3 EPIGENETIC AND GENETIC EFFECTS OF HIGH-INTENSITY INTERVAL TRAINING 34 
4.4 LIMITATIONS OF THE STUDY 36 
4.5 FUTURE DIRECTIONS 37 
5 CONCLUSION 39 
REFERENCES I 
APPENDIXES VII 
APPENDIX A: INFORMED CONSENT VII 
APPENDIX B: DETAILS OF THE SELECTED CPG SITES XIII 
APPENDIX C: MEASURED RNA CONCENTRATIONS AND DILUTION DETAILS XIV 
APPENDIX D: SET-UP FOR REAL-TIME QRT-PCR XVI 
APPENDIX E: REC APPROVAL XVII 
APPENDIX F: INDIVIDUAL CHANGES IN WEIGHT, BODY MASS INDEX, WAIST CIRCUMFERENCE AND BODY FAT 
PERCENTAGE XIX 
APPENDIX G: INDIVIDUAL CHANGES IN CIRCULATING BLOOD MARKERS OF CARDIOVASCULAR HEALTH XXI 
APPENDIX H: INDIVIDUAL CHANGES IN MAXIMAL AEROBIC CAPACITY XXIV 
APPENDIX I: INDIVIDUAL CHANGES IN DNA METHYLATION XXV 
APPENDIX J: INDIVIDUAL CHANGES OF GENE EXPRESSION XXVII 
 
 Introduction  
 1 
1 Introduction 
 
1.1 An aging population 
In Norway the life expectancy has increased about 30 years for the last 200 years1. The 
incidences of several diseases increase with age2,3. Some age-associated diseases are infection, 
cardiovascular disease (CVD), musculoskeletal weakness, cancer, and dementia2,3. As people 
continuously get older and diseases occur more frequently, health care centers are filled up and 
society’s economy is challenged2,4,5. 
 
1.2 Physical activity and health 
As people get older they are more physically inactive3,6. Several studies show that regular 
physical activity affects the health in a positive way and prevents diseases3,5,7-14. It is also known 
that exercise increases aerobic capacity5. In an article by Baldwin and Haddad the researchers 
address the importance of understanding the mechanisms behind exercise benefits. 
Furthermore, they mention that exercise and disease prevention probably will be the most 
important factors for the health industry in the next decades and beyond13.  
 
1.3 Aerobic capacity 
A normal procedure to determine a person’s aerobic capacity is by measuring the maximal 
oxygen uptake (VO2max, mL · kg-1 · min-1) by treadmill running or ergometer cycling to 
exhaustion5. VO2max is often defined as “the oxygen intake during an exercise intensity at which 
actual oxygen intake reaches a maximum beyond which no increase in effort can raise it”15. High 
aerobic capacity and good physical health are associated with 46% lower risk of dying of any 
cause6. A low VO2max is associated with higher risk of metabolic and CVD, as well as premature 
mortality16. People who perform 30 minutes of moderate daily activity, have been proven with 
significant higher VO2max than those who are sedentary6. The most important factors that affect 
the VO2max include gender, age, and body composition, whereas to improve the VO2max important 
factors are the person’s fitness at start and the exercise mode (intensity, duration, 
frequency)17,18. A study that included 6 weeks of high-intensity endurance training of sedentary 
young subjects presented an average increase in VO2max of 14%, however about 20% of the 
subjects were found with less than 5% improvement in VO2max16. Studies suggest that genes can 
be a contributor to an individual’s ability to improve aerobic capacity following regular 
exercise16-23. 
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1.4 Aging, trainability and their effect on aerobic capacity 
Men normally have a higher VO2max than women, and studies show that VO2max typically 
decreases with age5,6. A recently published Norwegian study report a reduction in VO2max of 11% 
for men >70 years old compared to 60-69 years old men24. Several other research groups have 
reported a similar decline in aerobic capacity by age of 13-25% decrease every decade25-28. The 
same Norwegian study also report that men above 70 years old have an average VO2max of 35.3 
mL · kg-1 · min-1 24. Diseases are major causes of inactivity among elderly and reduces their 
aerobic capacity5. Additionally, among the elderly generation many have minimal knowledge 
about exercise or lack personal exercise experience, and therefore do not exercise at moderate- 
to high-intensities5. The ability to maintain a high aerobic capacity is a major determinant of 
functional independence among the elderly6. If a person’s aerobic capacity gets really low, the 
performance of regularly daily activities can become a struggle6. 
 
To improve aerobic capacity, exercise is the solution16. Numerous studies have proven beneficial 
effects of exercise in elderly people5,8-10,29-32. The risk of exercise is demonstrated to be very low 
if the right precautions regarding warm-up and how the exercise is performed are taken into 
account33. A meta study by Kelley et al. found that aerobic exercise resulted in a significant 
decrease in body mass index (BMI, kg/m2) and percentage body fat, while VO2max increased by 
13% in older adults34. Studies that have documented a 10-25% increase in peak VO2, following 
endurance training in 60-80 year old adults5,35-37. 
 
The benefits of exercise occur through increased quantity and quality of physical activity, where 
factors as intensity, duration and frequency are important11,38. Intensity is often measured as 
percentage of maximum heart rate (HRmax)39. A paper by Helgerud et al. concludes that: “High-
aerobic intensity endurance interval training is significantly more effective than performing the 
same total work at either lactate threshold or at 70% HRmax, in improving VO2max.”39. This study 
also suggests that 4x4-minutes high-intensity interval training is one of the best exercise models 
for increasing ones VO2max39. Furthermore, several other studies have proven that high-intensity 
exercise is superior to moderate- or low-intensity exercise in improving VO2max9,32,38. Often 
exercise studies with elderly include moderate intensity, however high-intensity interval 
training studies with 65-70 years old men have been performed9,30,32. Still, more studies on 
elderly are needed to elucidate how high-intensity interval training affects aerobic capacity and 
health of the elderly above 70 years of age.  
 Introduction  
 3 
 
1.5 Effects of exercise on the lipid profile of cardiovascular health 
A lipid profile can indicate health status and the risk of CVD40. Several risk markers can be 
analyzed in a single blood sample. Some risk markers of CVD are total cholesterol (TC), 
triglycerides (TG), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) 
cholesterol, glucose and high-sensitivity C-reactive protein (hs-CRP)40. The risk markers have a 
reference value and if they are detected outside their range the risk of a cardiac event increase 
(reference values are included in Table 3.2)40,41. Studies have shown that aerobic exercise can 
reduce TC, TG and LDL cholesterol, while it increases HDL cholesterol34,42.  
 
1.6 Epigenetics and gene expression  
Through the last decades researchers have discovered molecular processes that can affect the 
human genome and participate in the development of several diseases43-49. These processes are 
called epigenetic changes. Epigenetic changes involve alterations of the genome, without 
changing the DNA sequence itself, and consists of chemical compounds that modify or mark the 
genome50. DNA methylation has been identified as an important epigenetic mechanism in the 
dynamic regulation of a genes expression, which is a complex but fine-tuned process where the 
information in the genome is used to synthesize a functional gene product44,51-55.  
 
DNA methylation 
DNA methylation is an epigenetic modification, described as the addition of the chemical methyl 
group (CH3) to the carbon number 5 of the nucleotide base cytosine in the DNA43,44,48,50 (Figure 
1.1). All cells in the human body contain essentially the same DNA, whereas the DNA 
methylation pattern may highly differ. DNA methylation is a dynamic but highly controlled 
process that forms different cell- and tissue types during development50. The methylation 
pattern can be passed on from cell to daughter cell, and they may be inherited from one 
generation to the next50. Furthermore, the process can also change during adult lifetime44,50. 
Hence, the patterns of DNA methylation are much like fingerprints, specific to each cell, tissue 
type, and individual44.  
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Figure 1.1: Left: Addition of a methyl group (CH3) to carbon number 5 on the cytosine base creates 5-
methylcytosine. Right: A small part of a DNA-strand. Cytosine bases in the DNA become methylated, often 
in CpG islands of the promoter regions. The figure is a reprint from the webpages of The Life 
Technologies56. O: oxygen; C: carbon; N: nitrogen; NH2: amine group, CH3: methyl group; M: methyl group; 
G: guanine, C: cytosine; T: thymine, A: adenine. 
 
In humans, DNA methylation often occurs in CpG islands that are clusters of CpG dinucleotides 
(when a C and a G is connected with a phosphodiester bond) in GC-rich regions, and average 
about 1kb in length44,53. The human genome consists of approximately 30 000 000 CpG 
dinucleotides (or CpG sites) and about 6% of all CpG sites are located in the CpG islands57. There 
are estimated around 37 000 CpG islands within the human genome53. Approximately 65% of 
the CpG islands of the human genome are gene-associated, and around 11 000 of them overlap 
transcription start sites (TSS)44,53. The methyl groups affect the interactions between DNA and 
the cells transcription machinery and have important regulatory functions44,50.  
 
Numerous approaches have been developed to detect methylation patterns, like the Illumina 
bisulfite based array system58. Here, bisulfite converted DNA samples are added to an Illumina 
microarray, and methylation levels of 450 000 CpG sites can be detected within the same 
sample58,59. Sample throughput is however to some extent limited by the costs of the analysis58. 
One Illumina microarray often include 12 or 24 samples59. 
 
Gene expression 
Gene expression is the process where the information from a gene is used in the synthesis of a 
functional gene product51. Gene expression is often divided into steps like transcription, RNA 
processing and translation51. Normally, transcription begins at the TSS in the promoter region of 
the encoding DNA sequence, and RNA is transcribed51. The RNA is then processed into a 
messenger RNA (mRNA), and follows translation into a functional product, which is usually one, 
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or several proteins51. Only a fraction of the genes in a cell is expressed at any one time and 
different cells express different combinations of genes51. The timing, location, and amount of 
gene expression profoundly affect the action and function of the gene in the organism51. Hence, 
gene expression is the most fundamental level at which genotype gives rise to the phenotype51.  
 
Numerous approaches have been developed to analyze gene expression. Gene expression is 
often investigated by quantitative (q) real-time reverse transcriptase (RT) polymerase chain 
reaction (PCR), which detect the transcription of specific genes at a certain time point with 
measurements of the amount of RNA in the sample60. 
 
1.7 Effects of DNA methylation on gene expression 
It is generally accepted that a high levels of methylation in promoter CpG islands results in gene 
silencing and that CpG islands are normally unmethylated in actively transcribed genes (Figure 
1.2)57.  
 
Figure 1.2 Unmethylated CpG islands are associated with an active gene, whereas a methylated CpG 
island is associated with repressed gene expression. The figure is a reprint from the webpage of The 
University of California61.  
 
Hypermethylation typically decreases transcription, whereas hypomethylation increases the 
transcription of downstream genes44,52-54. Hence, DNA methylation is an effective means by 
which gene expression is silenced, which may occur by different approaches44,50,54,62. DNA 
methylation of gene promoters may interfere with the binding of certain transcription factors 
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(TF's), it can attract methylated DNA-binding proteins that in turn recruit other modifying 
enzymes and hinder transcription, or it may lead to chromatin configuration that is unfavorable 
for gene expression52,54,62.  
 
Most changes of DNA methylation are probably harmless, but some changes have been proven to 
trigger or increase the severity of diseases43,44. This makes DNA methylation a vital part of 
efforts to better understand the human body and improve human health. 
 
1.8 Causes of change in DNA methylation 
Several factors have been proven to have an effect on DNA methylation, such as age, gender, 
lifestyle and environment44,55,63. DNA methylation is known to be higher in men, and in older 
people55. The cause of the variations is not fully understood44. Lifestyle and environmental 
factors can expose a person to chemical tags that change the epigenome44,50,63. Environmental 
factors such as diet, caffeine, and alcohol consumption have been shown to alter DNA 
methylation44,63. Additionally, exercise is believed to have an effect on DNA methylation as well63. 
A study by Barres et al. recently addressed this theory and proved that acute exercise caused 
transient changes in DNA methylation in adult skeletal muscle63. The workout demethylated the 
promoter regions of metabolic genes, whereas genes unrelated to the metabolism remained 
unmethylated63. The same study also found that the amount of demethylation of the promoters 
increased with the intensity of the exercise63. Furthermore, aberrant DNA methylation has been 
associated with various diseases, such as inflammation diseases, cancer or CVD43-45,48,49,54.  
 
1.9  The future of epigenetic and exercise in relation to health 
In an article by You et al. the author address that in the future, new knowledge about the 
epigenome may benefit human health and provide new opportunities for improvement of 
therapies, and adds that the epigenome needs more research49. The mentioned study by Barres 
et al. addressed a potential relationship between exercise and epigenetics, and proved an acute 
decrease in DNA methylation in response to a single-bout of endurance training63. More research 
is needed to determine whether regular exercise can change the DNA methylation in a more 
long-lasting state, and to determine the causes and consequences of these exercise-induced 
changes.  
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1.10 The research hypothesis 
In the present project we wanted to investigate whether regularly high-intensity interval 
training could provide long-term changes in DNA methylation of the human genome, and 
whether these changes could affect gene expression. Our null hypothesis was that no such 
changes in DNA methylation or gene expression could be detected.  
 
1.11 Research objectives 
 
 The primary research objective was to uncover non-acute changes in DNA methylation 
in promoter regions of specific genes in muscle tissue from high-intensity interval 
training subjects. 
 The secondary research objective was to expose an inverse relationship between the 
change in DNA methylation of a specific gene and the expression of the gene.  
 
Furthermore, additional research objectives were to explore the effects of high-intensity 
interval training on specific health factors and address possible complications of exercising 
considering the age of the subjects. 
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2 Experimental procedures and methods 
To test the research hypothesis we measured the changes in DNA methylation and gene 
expression in skeletal muscle tissue before and after an exercise intervention, in old men. 
Furthermore, we measured the changes in VO2max, BMI, waist circumference, fat percentage, and 
risk markers of CVD in blood from the same subjects. We analyzed the changes within each 
group (cases and controls, from baseline to follow-up), and also compared the difference in 
changes between the groups. 
 
2.1 Subjects 
This project was performed in collaboration with a study called Generation100 (Gen100), at 
NTNU, Faculty of Medicine, Department of Circulation and Medical Imaging. Gen100 addresses 
whether exercise has an effect on morbidity and mortality among elderly in Norway. Men and 
women in Trondheim, born in 1936-1942, were asked to participate in the Gen100-project. 
Participants were randomized into one of three groups; control group, moderate-intensity 
exercise training group, or high-intensity interval training (HIIT) group.  
 
Twenty-six men (70-75 years old) were recruited from Gen100 to the present project, where 
participants were already randomized into groups. Thirteen men were recruited for each of the 
following groups: (1) HIIT group or (2) control group. The number of participants was based on 
estimations from previous studies at NTNU and similar studies from literature, with 
reservations of subjects withdrawing. A purpose of the project was to recruit participants at 
same age and gender, and train them with the same intensity, duration and frequency to avoid 
differences of these important factors affecting the results.  
 
2.1.1 Inclusion and exclusion criteria 
All participants had to approve their participation and sign a written, informed consent before 
their involvement in the study (Appendix A). Participants were free to withdraw from the study 
at any time and without further questioning. Further inclusion and exclusion criteria are 
presented in Table 2.1. 
 
  
 Experimental procedures and methods  
 10 
Table 2.1: Inclusion and exclusion criteria for participants in the project.  
Inclusion criteria  Male 
 70-75 years old 
 Randomized to HIIT or control group in Gen100 
Exclusion criteria  Incompatible with exercise 
 Known cardiac disease 
 Active cancer 
 Significant pulmonary disease 
 Uncontrolled hypertension 
 Use of blood thinning medicine (except Albyl-E) 
 Drug abuse 
 Alcohol abuse 
 Finishing <80% of the exercise sessions (this only 
complies to the HIIT group) 
HIIT: high-intensity interval training; Gen100: The Generation100-study 
 
Ten men finished the project period, whereas three men dropped out in each group. Two men 
withdraw from the HIIT group and did not complete the exercise period. The first withdraw 
from personal reasons, and the second was unable to perform exercise because of severe back-
pain (not caused by this project). Another man was later excluded from the HIIT group because 
he was diagnosed with significant pulmonary disease. Three men from the control group were 
excluded; two because they were unable to finish the follow-up tests because of personal 
reasons and one for changing his dietary pattern and exercise habits significantly during the 
project (lost 13 kg). For the distinctive laboratory analysis specific numbers of participants were 
included, and some subjects had to be excluded during data analyses, more details in Table 2.2. 
 
  
 Experimental procedures and methods  
 11 
Table 2.2: Number of included and excluded subject within all analyses, as well as the final valid number 
of subjects in the analyses, separated by groups: control and high-intensity interval training (HIIT) group. 
 Included subjects 
Excluded subjects 
in data analysis 
Valid number of 
subjects in analysis 
Analyses HIIT Control HIIT Control HIIT Control 
BMI, waist circumference, body fat, 
VO2max, and blood markers 13 13 3 3 10 10 
DNA methylation analyses 6∫ 6∫ 0 3‡ 6 3 
Gene expression of MYH1 10 9◊ 2† 1† 8 8 
Gene expression of VDAC2 10 9◊ 1† 0 9 9 
Gene expression of BNIP3 10 9◊ 1† 1† 9 8 
Gene expression of COX16 10 9◊ 0 0 10 9 
∫: Restricted numbers of samples included because of the high costs of performing this analysis;   ‡: Excluded because 
they became “outliers” during the analysis on the Illumina microarray and were found fallacious; ◊: There was not 
enough muscle tissue from the last control to isolate RNA from; †: Excluded because of inadequate parallels; BMI: 
body mass index; VO2max: maximal aerobic capacity; MYH1: Myosin Heavy Chain 1; VDAC2: voltage-dependent anion 
channel 2; BNIP3: BCL2/adenovirus E1B 19kDa interacting protein 3; COX16: Cytochrome C Oxidase Assembly 
Homolog. 
 
2.2 Sampling procedure  
Baseline measurement of height, weight, BMI, body fat, waist, VO2max, and HRmax were performed 
in collaboration with Gen100 before the participants were randomized, and involved in the 
present project. A second baseline day was arranged to collect blood and skeletal muscle 
samples particularly for the present project. After baseline tests were performed the HIIT group 
started a eight weeks exercise period, whereas the control group was instructed to live normally. 
Then, individual follow-up tests were performed continuously. The follow-up test of VO2max and 
HRmax was performed as the individuals last exercise session in the HIIT group, and after 8 
weeks for the control group. The follow-up measurements of weight, BMI, body fat, waist, as well 
as collection of blood samples and muscle biopsies were scheduled two days later, to avoid acute 
effects of the treadmill test in the measurements. Therefor the participants were also specifically 
requested to avoid exercise during the 48-72 hours between these two tests. All measurements 
of weight, BMI, body fat, waist circumference, as well as blood samples and muscle biopsies 
were collected on a fasting stomach, whereas tests on treadmill to obtain measurements of 
VO2max and HRmax were performed non-fasting. The project procedure is illustrated in Figure 2.1. 
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Figure 2.1: Project procedure. The inclusion and baseline tests were performed in collaboration with 
Gen100. Then, the participants were randomized, and included to the present study. The intervention 
period lasted for 8 weeks. BMI: body mass index; VO2max: Maximal aerobic capacity; HRmax: Maximal heart 
rate; MIT: Moderate-intensity training group; HIIT: High-intensity interval training group; n: Number of 
subjects; TG: Triglycerides; TC: Total cholesterol; HDL: High-density lipoprotein cholesterol; LDL: Low-
density lipoprotein cholesterol; hs-CRP: High-sensitivity C-reactive protein. 
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2.2.1 Height, weight, body mass index, body fat and waist circumference 
The standard procedures at The Clinical Research Facility at the St. Olavs Hospital were used to 
measure the height, weight, BMI, body fat percentage and waist circumference of the 
participants. The height was measured in meters (m) with one decimal and adjusted to the 
nearest 0.5 centimeter (cm). Weight, BMI and body fat percentage was measured using an 
instrument called Inbody 720 (BIOSPACE, Body Analysis AS, The southern region, Korea). Inbody 
720 also provided other measurements, as left-leg muscle mass that was used for decisions 
regarding latter DNA methylation analysis. Participants wore light clothes (top and trousers) 
and no shoes. The weight was measured in kilograms (kg) with one decimal. Body fat percentage 
was measured to the nearest 0.1%. BMI was automatically calculated as weight divided by 
square of height (kg/m2). The waist circumference was measured in cm with a regular 
measuring band, one cm over the navel and adjusted to the nearest 0.5 cm. It was ensured that 
all measurements during follow-up tests were taken at the same time of day as the baseline tests. 
 
2.2.2 Blood analyses of risk markers of cardiovascular disease 
Health personnel collected blood samples following standard procedures at St. Olavs Hospital. A 
3 mL Li-Heparin-tube was collected, sent and directly analyzed at The Medical Biochemistry 
Laboratory at St. Olavs Hospital. Parameters that were analyzed were TC, HDL cholesterol, LDL 
cholesterol, TG, glucose, and hs-CRP.  
 
2.2.3 Maximal aerobic capacity and maximal heart rate 
Measurements of VO2max and HRmax were completed during walking or running on the treadmill. 
The test was performed using MetaMaxII (CORTEX Biophysik, Leipzig, Germany) and its 
software MetaSoft3. To perform the maximal aerobic test on the treadmill the participants wore 
a mask, covering both their nose and mouth. The test began with 10 minutes warm-up, where 
the incline and speed was individually adjusted, based on the participants’ fitness level. After 
warm-up the next level was either to increase the incline of the treadmill by 2% or increase the 
speed by 1 km/h. The first increase was after 2-3 minutes for the values to stabilize. The 
increase continued when the level of oxygen uptake stabilized, approximately every one or two 
minutes. This protocol was carried out until the participant was no longer able to increase 
workload and had to stop because of exhaustion, as well as the criteria for maximal oxygen 
uptake had been reached. The best way to ensure that the participants had reached their true 
VO2max was to see that the oxygen curve had a straightening out or drop in spite of increased 
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workload on the treadmill.  In combination, a respiratory exchange ratio (RER, the ratio of 
carbon dioxide produced, to oxygen consumed) higher than 1.05, was used as criteria for 
exhaustion and that true VO2max had been reached. However, it is important to mention that 
reaching this value were not a criterion to stop the test. RER was only a factor to control how 
close to fatigue the participants were during the tests, so the test continued till the participant 
was exhausted and had to stop. Most of the participants reached RER-values of 1.15-1.20. During 
the working period measurements of oxygen uptake and heart rate were continuously 
monitored, using MetaMaxII and Polar Heart Rate Monitors, respectively. The three highest 
achieved oxygen uptakes during the test were used as average, and termed as VO2max. The 
highest heart rate during the test was ascribed 5 additional beats and assigned as HRmax (this is 
the procedure in Gen100 and has previously been done in another study64). The HRmax from the 
baseline test was used to calculate the individual heart rate during the exercise sessions. HRmax 
and RER-values did not change significantly from baseline to follow-up, which are good 
indications that the tests were performed in a right manner.  
 
2.2.4 Muscle biopsies from vastus lateralis 
Muscle biopsies were collected from all participants in both groups before and after the exercise 
period. The biopsy was obtained from the skeletal muscle vastus lateralis at the same site of the 
participants left thigh. The procedure was performed by a medical doctor using a sterile 5-mm-
diameter biopsy needle under local anesthesia (2% Lidocaine)65. First, a 5–10 mm incision was 
made and the biopsy needle was introduced into the muscle tissue without using suction. One 
additional person assisted the medical doctor during the surgical intervention. Three small 
muscle biopsies were collected from each participant, directly frozen in liquid nitrogen and 
stored at −80 °C in the biobank of Gen100 for later analyses. After the muscle tissue was 
collected, the patient got 2-3 stiches and compression for 10 minutes before finishing. The 
participants were followed up after the surgical procedure and the stiches were removed after 
7-10 days.  
 
2.3 The exercise period 
The HIIT group performed individually supervised high-intensity interval training on treadmills, 
three days a week for eight weeks at the exercise-facility at NTNU/St. Olavs Hospital. The control 
group had no follow-up on exercise during the 8 weeks. 
 
 Experimental procedures and methods  
 15 
2.3.1 High-intensity interval training group 
The HIIT group was instructed to complete exercise sessions of 4x4-minutes intervals at 85-95% 
of HRmax, which was selected as the exercise intervention based on previous studies presenting 
great improvement of VO2max with this type of exercise5,10,32,34,39. This type of exercise include 10 
minutes warm-up, followed by four intervals of four minutes high-intensity (85-95% of HRmax), 
with three minutes active breaks (70% of HRmax) between each interval, and ending with seven 
minutes cool-down. An exercise session last for 42 minutes, where the participants should 
breathe heavily and feel exhausted four times. Exercise intensity was supervised through the use 
of Polar Heart Rate Monitors, and speed and incline were adjusted continuously to ensure that 
each session was performed at the assigned intensity. Participants had a personal instructor 
following them at every exercise session. If participants could for some reason not show up for 
their exercise sessions they were rescheduled. All participants were able to finish all sessions. 
Most of the participants of the HIIT group were unfamiliar with treadmills and high-intensity 
interval training. However, they quickly got familiar with this type of exercise and managed to 
control the treadmills themselves. 
 
2.3.2 Control group 
The control group followed the baseline and follow-up tests, and was asked to live normally and 
not change their dietary pattern or exercise habits during their participation in this project. 
Based on the well-known beneficial effects of exercise on general health, it was regarded 
unethical to demand the control group to desist from any types of physical activity during the 
project period. They got no further follow-up on exercise. 
 
2.4 Wet laboratory analyses 
The collected muscle tissue was used for wet laboratory analyses of DNA methylation and gene 
expression. DNA was isolated from muscle tissue, bisulfite converted, and DNA methylation was 
analyzed by microarray analysis. Furthermore, RNA was isolated from muscle tissue, and gene 
expression was measured by quantitative real-time reverse transcriptase polymerase chain 
reaction (real-time qRT-PCR). The wet laboratory analyses process is illustrated in Figure 2.2.  
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Figure 2.2: Flow chart of the wet laboratory process, including the names of the kits used to analyze the 
muscle tissue samples. 
 
2.4.1 DNA methylation analysis 
Because of high costs of the DNA methylation analysis the number of samples had to be 
restricted, where change in VO2max and left-leg muscle mass were used as criteria for inclusion. 
From the control group, the subjects with the most stable VO2max and left-leg muscle mass were 
chosen to be included. From the HIIT group the subjects with the greatest improvements in 
VO2max, to be sure that they have had optimal benefits from the exercise intervention, and minor 
changes in left-leg muscle mass were included. It was assumed that these subjects would show 
the largest changes in methylation status after the exercise intervention. A stable left-leg muscle 
mass was a criteria to avoid changes of muscle mass to disturb the potential findings of change 
in DNA methylation.  
 
DNA isolation 
DNA, total RNA and proteins were isolated from muscle tissue samples (~20 mg) following the 
standards of the protocol AllPrep DNA/RNA/Protein Mini Kit (Qiagen, Hilden, Germany)66. Briefly, 
the muscle tissue was first lysed and homogenized in a buffer, containing guanidine-
isothiocyanate66. This buffer is highly denaturing and immediately inactivates DNases and 
RNases66. The lysate was then passed through an AllPrep DNA spin column66. In combination 
with high-salt buffer, the column selectively binds the genomic DNA from the tissue sample66. 
After washing, ready-to-use DNA was eluted from the column66. Furthermore, this kit also 
isolates total RNA and proteins from the same muscle tissue sample. The isolated RNA had low 
quantity, and thus another kit was used to isolate RNA to use in this project (see section 2.4.2). 
Isolated proteins were not used in this project. Therefore, both isolated RNA and proteins from 
this kit were directly stored at -80 degrees for prospect work. A NanoDrop 2000c/2000 UV-Vis 
Spectrophotometer (Thermo Fisher Scientific, Wilmington, USA) was used to measure the 
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260/280 Ratio and 260/230 Ratio, which determine the quantity and the purity of the isolated 
DNA67. All samples were found at acceptable levels, around 1.8 for the 260/280 Ratio and 2.0-2.2 
for the 260/230 Ratio67.  
 
Bisulfite conversion of DNA 
The isolated DNA was bisulfite converted following the standards of the protocol EZ DNA 
Methylation-Lightning™ Kit Bisulfite (Zymo Research, Irvine, USA)68. The kit converts 
unmethylated cytosine to uracil while methylated cytosine remain unchanged68. Quantity and 
purity of the bisulfite converted DNA was tested on the NanoDrop, whereas Bioanalyzer 2100 
(Agilent, California, USA) was used to control the degradation, to assure the quality of the 
samples. The quantity, purity and quality of the bisulfite converted DNA was found acceptable in 
all samples. 
 
Microarray analysis 
Bisulfite converted DNA was further administered by The Genomics Core Facility at NTNU, and 
DNA methylation analysis was performed following standards of the protocol Illumina Infinium 
HumanMethylation450 BeadChip Kit (Illumina, San Diego, USA)59.  
 
The Illumina HumanMethylation450 BeadChip is a microarray used for detection of DNA 
methylation level within more than 450 000 CpG sites of the human genome, both within and 
outside of genes and CpG island regions59. In general, microarray is a method where synthesized 
probes (a fragment of DNA or RNA that is able to hybridize to a specific target) are attached to a 
solid surface and used to detect nucleotide sequences of interest from a sample that are 
complimentary to the sequence in the probe69. A microarray can contain tens of thousands of 
probes, located within different “spots” on the array69. The target bind to the specific probe in a 
spot and the amount of target in a sample can be detected69.  
 
The HumanMethylation450 chip used in this project have micro wells where the individual 
samples are applied, and each well contain DNA methylation specific probes linked to specific 
bead types70,71. Each bead-bonded probe corresponds to the methylated or unmethylated state 
of each specific CpG site70,71. Basically, depending on the methylation status of the DNA sample, 
the sample will either bind to the methylation specific or the unmethylated specific probe70. The 
Illumina microarray is a trusted DNA analysis platform and contains 600 internal quality 
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controls59,72. The results from the Illumina microarray represent the DNA methylation level of 
the DNA samples and are presented as Beta values (the ratio of signal from the methylated 
probe relative to the sum of both methylated and unmethylated probes)55. The Beta value ranges 
from 0 (unmethylated) to 1 (completely methylated)55.  
 
To run statistical analyses of the results from the Illumina microarray the Beta values were 
converted to M-values as derived in the article of Du et al. from 201073. The conversion was done 
because of the heteroscedasticity of the Beta values, and to make them more suitable for 
statistical analyses73,74. Furthermore, the data was analyzed and a “Ranged list” was created, 
containing the CpG sites that had changed their DNA methylation status the most among the 
individuals. The subjects were compared to each other in terms of their change in VO2max. This 
means the individual samples were not compared considering which group they belonged to, 
but the change in DNA methylation was rather analyzed as a correlation to the individuals 
change in VO2max. This was considered the best way to compare the samples, because this 
method would also take the gradational amount of change of VO2max into account.  
 
Because of the high number of analyzed CpG sites and the low number of samples, Bonferroni 
corrections were performed (This method divides the critical p-value by the number of 
comparisons being made, to adjust the statistical analyses for multiple testing)75. This gives a 
significance level of these tests a p-value<1.1 x 10-7 (0.05/450 000). The “Ranged list” contains 
an insecurity of faulty detected CpG sites. Also, the list can be prepared in a many different ways 
considering its purpose. Thus, a literature search was performed to pick the CpG sites from the 
“Ranged list” considered of best biological interest, as well as most believable to be changed 
following an exercise intervention. The chosen CpG site were all part of CpG islands of promoter 
regions, which was also the case in the study of Barres et al., the central article of the present 
research hypothesis.  
 
The selected four CpG sites from the “Ranged list” became (Illumina ID): cg16842280, 
cg26801646, cg08079580, and cg23562388, presented with details in Appendix B. These four 
CpG sites are respectively associated with the promoter region of the genes MYH1, VDAC2, BNIP3, 
and COX16. MYH1 (Myosin Heavy Chain 1) is highly expressed in the skeletal muscle, whereas 
VDAC2 (voltage-dependent anion channel 2), BNIP3 (BCL2/adenovirus E1B 19kDa interacting 
protein 3), and COX16 (Cytochrome C Oxidase Assembly Homolog) are all genes that encode 
proteins of the mitochondrial membrane. Both skeletal muscle and mitochondria are highly 
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active during exercise and therefore these CpG sites were considered of our biological interest, 
because of the projects exercise intervention.  
 
The change in DNA methylation of the four CpG sites from baseline to follow-up is presented in 
this report as delta values (follow-up Beta value/baseline Beta value). A delta ratio >1 indicates 
an increase in DNA methylation from baseline to follow-up, whereas a ratio <1 indicates a 
decrease in DNA methylation. 
 
2.4.2 Gene expression analyses 
RNA was isolated from muscle tissue samples and analyzed by real-time qRT-PCR to detect gene 
expression of the four chosen genes MYH1, VDAC2, BNIP3, and COX16.  
 
RNA isolation 
RNA was isolated from muscle tissue samples (~30 mg) following the standards of the protocol 
miRNeasy Mini kit (Qiagen, Hilden, Germany)76. Briefly, the muscle tissue was lysed and 
homogenized in the QIAzol Lysis Reagent, using beads and the TissueRuptor Mixer Mill Type MM 
301 (Retsch GmbH & Co., Haan, Germany). Then, spin columns was used to separate sections, 
then bind, wash, and elute high-quality RNA from the samples76. The QIAzol Lysis Reagent in this 
kit is a solution of phenol and guanidine thiocyanate, which inhibits RNases from degrading the 
unstable RNA, and also removes most of the cellular DNA and proteins from the lysate76. The 
NanoDrop was used to measure the 260/280 Ratio and the 260/280 Ratio to determine the 
concentration and purity of the isolated RNA67. All samples were found at acceptable levels, 
around 2.0 for the 260/280 Ratio and 2.0-2.2 for the 260/230 Ratio67. After RNA concentrations 
were measured every sample was diluted to a concentration of 90 ng/µL by adding appropriate 
amounts of RNase free water. The RNA concentrations and dilution details are added in 
Appendix C. 
 
Quantitative real-time reverse transcriptase polymerase chain reaction 
The isolated RNA with a concentration of 90 ng/µL was analyzed by real-time qRT-PCR, 
detecting the expression of the four genes MYH1, VDAC2, BNIP3, and COX16. Using QuantiFast 
Probe Assay (Qiagen, Hilden, Germany) in combination with QuantiFast Probe RT-PCR Plus Kit 
(Qiagen, Hilden, Germany) the PCR process was performed following the standard protocol for 
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one-step duplex detection77,78. The assay contains premixed and specific primer pairs, and is 
designed to detect hydrolysis probes in a single step RT-PCR77. Briefly, the principle of these 
hydrolysis probes and the PCR process is explained in Figure 2.377.  
 
 
Figure 2.3: The principle of the real-time qRT-PCR and the detecting of fluorescence from the probes 
during PCR amplification. Top: During the PCR annealing step, both the probe and the primers anneal to 
the RNA target sequence (template). The proximity of the fluorophore (R) with the quencher (Q) prevents 
the probe from fluorescing. Bottom: During the PCR extension step, DNA polymerase extends the primer. 
When DNA polymerase reaches the probe, the fluorophore is cleaved from the probe and emit a 
fluorescent detectable signal. This results in a detectable fluorescence that is proportional to the amount 
of accumulated PCR product. The figure is a reprint from the article of Ali and Ali79. 
 
Four assays were performed in total, one for each of the four chosen genes MYH1, VDAC2, BNIP3, 
and COX16. 96-wells plates were used, and all samples and experimental controls were run in 
parallels. The set-up for the real-time qRT-PCR analyses can be found in Appendix D. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the reference gene. 
Carboxyfluorescein (FAM) was used as reporter dyes for the target gene and hexachloro-6-
carboxy-fluoresceine (HEX) was used as reporter dyes for the reference gene. The choice of 
GAPDH as the reference gene was supported by a study that concluded that GAPDH and β2M 
were the most stably expressed reference genes in skeletal muscle following endurance 
exercise80. In the present project GAPDH were stable and showed no significant variation in the 
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gene expression analyses. Also, a no-template control (NTC) and a no-reverse transcriptase 
(NRT) control were included into the assay, where no amplification should be detected, to be 
able to prove that the signals obtained from the target samples were valid and specific. To run 
the real-time qRT-PCR process the BioRad CFX96 real-time PCR thermal cycler (BioRad 
Laboratories Inc., California, USA) was used. The Bio-Rad CFX Manager Software 2.0 (2009) 
delivered the results that were subsequently handled manually.  
 
The cycle threshold (Ct) were detected for every well, which is the cycle number where the 
fluorescent signal of the reaction crosses the set threshold (manually adjusted)60. The Ct value 
was used to calculate the initial amount of the specific RNA in each sample60. The Ct value is 
inversely related to the starting amount of your target60. If the Ct value increase with one cycle 
the sample will contain double of the starting amount (assuming 100% efficiency)60.  Figure 2.4 
shows how the results from the real-time qRT-PCR are illustrated, which include threshold line, 
and detected fluorescence’s (both for the reporter gene and the target gene) in every individual 
samples and the controls. 
 
 
Figure 2.4: Graphical results from duplex run of real-time RT-qPCR. Threshold is here shown as a straight, 
horizontal line at approximately 200 relative fluorescence units (RFU), right above the detected 
background and controls. Green lines represent the reference gene (HEX as reporter dye) and blue lines 
represent the target gene (FAM as reporter dye), and are both detected in every individual sample. 
 
The Ct values were analyzed using comparative quantification where the ∆∆Ct-algorithms were 
used60. The method compares the results from the experimental samples (here: the HIIT group 
Threshold line 
Detected fluorescence’s in every 
individual sample: 
Green line: Reference gene  
Blue line: Target gene  
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samples) with both a calibrator (here: the control group samples) and a normalizer (here: the 
reference gene GAPDH)60. Mean values of the parallels were used. Using this method, the Ct value 
for the gene of interest (GOI) in both the experimental samples (s) and calibrator samples (c) 
were adjusted in relation to a normalizer (norm) gene’s Ct from the same two samples60. The 
∆∆Ct values were incorporated to determine the fold change in gene expression, following these 
equations (1-4)60: 
 
Fold change = 2-∆∆Ct           (1) 
∆Ct sample - ∆Ct calibrator = ∆∆Ct         (2) 
Ct GOI s – Ct norm s = ∆Ct sample         (3) 
Ct GOI c – Ct norm c = ∆Ct calibrator         (4) 
 
A fold change <1 denote a decrease in gene expression from baseline to follow-up, whereas a 
fold change >1 represent an increase. 
 
2.5 Ethics 
All subjects recruited for the study participated voluntarily. Participants got written information 
about the project and had to sign an informed consent before their involvement in the study, 
which also included that their biological material could be used in this project. The study 
personnel had to ensure that every subject understood what participation in this study involved, 
and also informed about possible side effects that could occur. Participants were free to 
withdraw from the study without reason, and were free to choose whether collected data could 
be used in further research or not. If risk markers of CVD were detected outside reference 
intervals in blood samples, the results were reported back to the subject with a requirement to 
contact his family doctor. All data was treated confidentially to protect the participants’ privacy. 
All employees in the project had professional secrecy. The samples and data that were 
registered about the participants were only used in accordance with the purpose of the study. 
Gen100 and the present project were both undertaken in accordance with the Helsinki 
declaration, and approved by the Regional Ethical Committee (REC, Gen100 ref. nr: 2012/381, 
Present project ref. nr: 2012/823b). The REC approval for the present project is added in 
Appendix E. 
 
 Experimental procedures and methods  
 23 
2.6 Biobank 
The biobank for Gen100 was used for storage of muscle tissue samples. This biobank was 
located at Heart and Lung Center, St. Olavs Hospital. Professor Ulrik Wisløff had the 
responsibility for the biobank. All the data and samples were processed without name, ID 
number or other directly recognizable type of information. A serial number linked each 
participant to their data and samples through a list of names. All personal information and data 
collected were stored in a locked place, and only the responsible researchers had access to the 
list that linked the serial number to personal information.  
 
2.7 Statistics  
Statistical analyses were performed using the software program SPSS, version 20.0 (IBM SPSS, 
New York, USA). Means and standard deviations (SD) for all variables were computed using 
descriptive statistics. Delta values (follow-up/baseline) were calculated for each variable, and 
represent a fold change. Generally, a fold change>1 shows an increase of the variable from 
baseline to follow-up, whereas fold changes<1 represents a decrease. All variables were tested 
with Shapiro-Wilk test, but because of the low number of participants all variables were 
accepted as nonparametric. Wilcoxon signed rank test was used to detect exact significant 
changes within the groups, from baseline to follow-up. Delta values were analyzed by Mann-
Whitney U test, to find exact significant difference in changes between the two groups. 
Correlations of delta values were analyzed by Crosstab correlation statistics using Pearson test, 
where DNA methylation of the four CpG sites and the respective genes expression data were 
correlated. Exact 2-tailed significant p-values were used for all the tests. Significance levels for 
all tests were set to p<0.05 and trends were set to p<0.10. Figures were made using Chart 
builders in SPSS or excel. All the statistical tests were performed with advices and support from 
the Unit for Applied Clinical Research at The Faculty of Medicine.  
 
The Genomics Core Facility, NTNU, provided the microarray service, and bioinformatics scientist 
Einar Ryeng performed the statistical analyses of the results from the Illumina microarray. 
Considering the projects selections and requests he performed statistical analyses using 
Principal Component Analysis (PCA) and Linear Models for Microarray Data (Limma). To adjust 
for the high number of detected CpG sites Bonferroni corrections were used75. Thus, the 
significance level for these analyses were set to p<1.1x10-7.  
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3 Results 
 
3.1 Body mass index, body fat and waist circumference 
Descriptive data of BMI, body fat and waist circumferences for the study population is 
summarized in Table 3.1. The results present a significant decrease in BMI (p<0.05) and waist 
circumference (p<0.01) in the HIIT group, with an average decrease of 1.7% and 5.5%, 
respectively. There was also detected a trend of 0.6% decrease in body fat within the HIIT group 
(p<0.1). A significant decrease in waist circumference was detected in the control group with an 
average decrease of 2.5% (p<0.05), however, the HIIT group experienced a significantly larger 
decline in waist circumference compared to the control group. No significant changes were 
detected for BMI or body fat percentage in the control group. The individual changes of weight, 
BMI, body fat percentage and waist circumference are added in Appendix F.  
 
Table 3.1: Mean values of body mass index, body fat and waist circumferences at baseline and follow-up. 
 HIIT group (n=10) Control group (n=10) 
Baseline (SD) Follow-up (SD) Baseline (SD) Follow-up (SD) 
BMI, kg/m2 28.9 3.8 28.4 3.7 *§ 26.5 2.2 26.5 2.3 
Body fat, % 29.8 6.9 29.2 6.9 25.8 4.0 26.0 3.7 
Waist, cm 103.7 10.6 97.9 8.2  **§ 100.3 7.4 97.8 9.2 * 
*: Significantly different from baseline, p<0.05; **: Significantly different from baseline, p<0.01; §: Significantly 
different from control group in change from baseline to follow-up, p<0.05. Values are meanSD. SD: Standard 
deviation; HIIT group: High-intensity interval training group; n: number of participants; BMI: Body mass index. 
 
3.2 Circulating blood markers of cardiovascular health 
Descriptive data of the blood marker analyses is presented in Table 3.2. The control group was 
found with a significant 8% decrease in HDL cholesterol (p<0.01), and the change was 
significantly different from the HIIT group (p<0.05). The blood markers TC, LDL, TG, glucose and 
hs-CRP did not change significantly. All mean values of the groups were detected inside the 
reference intervals41. Individual data on the blood markers are presented in Appendix G. 
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Table 3.2: Blood markers of cardiovascular health at baseline and follow-up. Reference values from St. 
Olavs Hospital where the normality of the population spans are presented. 
 HIIT group (n=10) Control group (n=10) Reference 
values from 
St. Olavs 
Hospital41 Baseline (SD) Follow-up (SD) Baseline (SD) Follow-up (SD) 
Total cholesterol 
(mmol/L) 
5.50 0.77 5.46 0.81 5.73 1.18 5.93 1.43 3.90-7.80 
LDL cholesterol 
(mmol/L) 
3.40 0.63 3.46 0.79 3.53 1.26 3.90 1.36  2.00-5.30 
HDL cholesterol 
(mmol/L) 
1.58 0.52 1.55 0.51 § 1.71 0.51 1.57 0.47 ** 0.80-2.10 
Triglycerides 
(mmol/L) 
1.15 0.40 1.02 0.32 1.09 0.26 1.02 0.16 0.45-2.60 
Glucose  
(mmol/L) 
5.89 0.47 5.82 0.86 5.90 1.19 6.06 1.52 4.20-6.30 
hs-CRP  
(mg/L) 
4.70 10.27 1.67 1.00 2.47 2.44 2.47 1.98 0.00-5.00 
**: Significantly different from baseline, p<0.01; §: Significantly different from control group in change from baseline 
to follow-up, p<0.05. Values are meanSD. SD: Standard deviation; HIIT group: High-intensity interval training group; 
n: number of participants; LDL cholesterol: Low-density lipoprotein cholesterol; HDL cholesterol: High-density 
lipoprotein cholesterol; hs-CRP: High-sensitivity C-reactive protein.  
 
3.3 Maximal aerobic capacity 
The HIIT group had a significant increase in VO2max (p<0.01), and the change was also significant 
compared to the control group (p<0.01) (Table 3.3).  
 
Table 3.3: Maximal aerobic capacity, heart rate, and respiratory exchange ratio at baseline and follow-up. 
 HIIT group (n=10) Control group (n=10) 
Baseline (SD) Follow-up (SD) Baseline (SD) Follow-up (SD) 
VO2max, mL  kg-1  min-1 29.4 4.4 33.7 5.1**§§ 31.6 5.1 32.6 5.5 
HRmax, heartbeats  min-1 167.212.9 167.713.5 153.919.8 156.914.1 
RER 1.160.07 1.130.05 1.130.03 1.110.05 
**: Significantly different from baseline, p<0.01; §§: Significantly different from control group in change from baseline 
to follow-up, p<0.01. Values are meanSD. SD: Standard deviation; HIIT group: High-intensity interval training group; 
n: number of participants; VO2max: Maximal aerobic capacity; HRmax: maximum heart rate; RER: Respiratory exchange 
ratio.  
 Results  
 27 
 
The participants in the HIIT group had an average improvement of 14.6% in VO2max after the 
exercise intervention. The fold change in VO2max (follow-up/baseline) within the two groups is 
shown in Figure 3.1. A fold change>1 represents an improvement in VO2max, whereas fold 
change<1 represents a decrease from baseline to follow-up. 
 
Figure 3.1: Fold change in maximal aerobic capacity in high-intensity interval training (HIIT) group and 
control group. Mean value  SD. SD: Standard deviation **: Significantly different from baseline, p<0.01; §§: 
Significantly different from control group in change from baseline to follow-up, p<0.01. 
 
The individual improvements of VO2max in the HIIT group ranged from a 3% to a 28% increase. 
The controls individually ranged from a 7% decrease to a 12% increase, but the group had no 
significant change. Figure 3.2 shows mean valuesSD of VO2max within groups illustrated in bars, 
at baseline and follow-up. Additionally, it includes lines representing each individual, illustrating 
the differences in initial VO2max and the change in VO2max. Individual data of VO2max are presented 
in Appendix H. 
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Figure 3.2: Bars represent changes in VO2max (mean  SD) at baseline and follow-up. Lines represent 
individuals and their change from baseline to follow-up. Left: High-intensity interval training group with a 
significant change of VO2max within the group (**) as well as compared to the change of the control group 
(§§), with p<0.01. Right: Control group show no significant (NS) change in VO2max. SD: Standard deviation. 
 
3.4 DNA methylation 
The DNA methylation delta ratios from the Illumina microarray for the four chosen CpG sites are 
presented in Figure 3.3. The detected global DNA methylation from the Illumina microarray was 
about 51% for every sample, only separated by the seventh decimal. However, differences were 
detected between the groups in terms of changes in DNA methylation of the four chosen CpG 
sites in the promoter region of MYH1, VDAC2, BNIP3, and COX16, where all four CpG sites 
changed in opposite directions in the two groups, but no significance could be detected. In more 
details, the DNA methylation of the CpG site in the promoter region of MYH1, VDAC2, and COX16 
decreased in the HIIT group (13.5%, 14.3% and 15%, respectively) whereas it increased in the 
control group (23.4%, 13.6% and 12.5%, respectively). The DNA methylation of the promoter 
region of BNIP3 increased with 25.7% in the HIIT group whereas it decreased 10% in the control 
group. Individual data on DNA methylation are presented in Appendix I. In the individual results 
from DNA methylation two subjects especially stood out from the others, one subject from each 
group, discussed in section 4.3.   
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Figure 3.3: Fold change of DNA methylation in the four CpG sites of the promoter regions of the genes 
MYH1, VDAC2, BNIP3, and COX16. Figure shows mean Beta values  SD within both groups. SD: Standard 
deviation; n: Number of subjects.  
 
3.5 Gene expression 
Fold change of gene expression (2-∆∆Ct) is shown for MYH1, VDAC2, BNIP3, and COX16 in Figure 
3.4. A significant change in gene expression was detected for MYH1 within the control group 
(p<0.05), where the expression increased by 3.25-fold during the study period. The expression 
of the same gene increased1.47-fold after the exercise intervention in the HIIT group, but the 
change was not significant. No significant changes of gene expression were detected for VDAC2, 
BNIP3 or COX16 within neither of the two groups. Furthermore, no significant changes were 
detected in gene expression of MYH1, VDAC2, BNIP3 or COX16 between the groups either. 
Individual data on gene expression is shown in Appendix J. One subject from the control group 
clearly differed from the other subjects in change of MYH1 gene expression.  
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Figure 3.4: Fold change (2-∆∆Ct) of gene expression for the four genes MYH1, VDAC2, BNIP3, and COX16, 
within each group. *: Significantly different from baseline, p<0.05. Figure shows mean values  SD. SD: 
Standard deviation; Ct: cycle threshold. 
 
3.6 Correlation analyses of changes in DNA methylation and changes 
in gene expression  
No significant correlations were detected in either group when correlating changes in DNA 
methylation of the four specific CpG sites and the changes in expression of the four respective 
genes; MYH1, VDAC2, BNIP3, and COX16. 
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4 Discussion 
The main findings of this study were that eight weeks of high-intensity interval training in 
elderly men resulted in a significant increase in VO2max and a significant decrease of BMI and 
waist circumference. These changes are likely to have improved the participant’s general and 
cardiovascular health, even though we were not able to show any changes in blood parameter’s 
reflecting cardiovascular health5,34,40. Furthermore, no adverse side effects were detected by the 
exercise intervention, supporting earlier evidence that high-intensity interval training is a safe 
prevention strategy even in men aged 70-75 years old33. 
 
Regarding DNA methylation, the Illumina microarray analysis indicated a possible correlation 
between changes in VO2max and changes in DNA methylation of the promoter regions of the 
genes MYH1, VDAC2, BNIP3, and COX16. Despite changes in DNA methylation of a CpG site in the 
promoter of these genes, no significant correlations were found between the changes in DNA 
methylation and the changes of gene expression. Additionally, no significant difference could be 
detected between the groups in changes of gene expression. This may indicate that the change in 
DNA methylation of these particular CpG sites did not have an effect on gene expression of these 
particular genes.  
 
Following, the results give reasons to believe that an improved VO2max can affect the naturally 
occurring changes of DNA methylation. However, larger and more extensive studies are needed 
to determine whether high-intensity interval training actually changes DNA methylation, and 
whether these changes have functional effects on transcription.  
 
4.1 High-intensity interval training in elderly 
The project demonstrates that exercise at intensities above 85% of HRmax was not associated 
with any specific complications or injuries among 70-75 year old men. Explaining the principles 
of 4x4-minutes intervals for the participants seemed to be a motivating factor for the subjects to 
perform the exercise sessions. Also, the efficiency of the exercise sessions (only 42 minutes to 
finish), along with the variation of regulating speed and incline during the sessions appeared as 
encouraging for the subjects. Furthermore, five months after the exercise period ended, HIIT-
participants could tell that they still perform the same 4x4-minutes regime 2-3 times a week on 
their own, because they liked the efficacy of the session and the effects this type of exercise give 
them. Many elderly share the opinion that exercise at high intensities are only for young people5. 
 Discussion  
 32 
However, this project address that with the right motivating factors, also the elderly are able to 
perform high-intensity interval training and can benefit from it.  
 
4.2 Positive health effects of high-intensity interval training 
This project showed that eight weeks of high-intensity interval training resulted in a likely 
improvement of the participant’s general and cardiovascular health, which was anticipated 
considering earlier studies34,81,82.  
 
Effects on body mass index, waist circumference and body fat percentage 
At baseline both groups were classified as overweight, regarding their BMI, body fat percentage 
and waist circumference, which are all well-known factors to increase with age81-84. Furthermore, 
high BMI or large waist circumference are known as important risk factors of several diseases, 
like heart disease, type-2 diabetes, and high blood pressure81,82,84. The present study found an 
exercise-induced decrease in these risk factors, which may reduce the participant’s risk of CVD84. 
Additionally, it may improve the respiratory function, sleep, functional capacity, the daily 
activity ability, depressive symptoms, sense of well-being and quality of life84. However, it is still 
not clear which cut-off values of BMI, waist circumference and body fat percentage that predicts 
the best health risks in obese elderly84. No significant change was detected in body fat 
percentage within the groups. This is supported by a study by Nybo et al. where also no 
significant change in fat percentage was detected after 12 weeks of high-intensity interval 
training82. In contrast, the same study also included subjects performing prolonged moderate 
endurance training, which induced a significant reduction in fat percentage82. This indicates that 
the duration of the exercise, rather than high-intensity, is a more important factor for improving 
fat percentage.  
 
Effects on blood markers of cardiovascular health 
According to the detected values of the blood markers no participants were considered at high 
risk of CVD. However, the control group showed a significant decrease in HDL cholesterol, which 
is considered non-beneficial for their health41. Furthermore, only small changes were detected in 
the blood markers within both groups, where the SD’s express the natural variations between 
the individuals. Such individual variations were clearly shown in the hs-CRP at baseline in the 
HIIT group, where the SD was detected at 10.27. This SD reflects that one subject clearly differed 
from the others; the reason is probably that this subject had an uncomplicated viral respiratory 
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tract infection, or “the flue”, which often occur among Norwegians at these times of year. This is 
supported by the fact that the same individual was detected at normal levels of hs-CRP in the 
follow-up test, and therefore was not considered at higher risk of CVD. A raised hs-CRP could 
have affected the VO2max-test, but the RER-values and HRmax measured during the tests indicate 
no support to these possibilities.  The raised hs-CRP is not considered to be of high influence on 
any of the other factors or tests.  
 
The reasons why few changes occurred in the blood markers may be that the duration of the 
exercise period or that each exercise session was too short. This is supported by a study that 
indicates that exercise volume rather than intensity is more important for the improvement of 
the lipid profile82. Other previous studies have detected decreased levels of TC, TG, LDL 
cholesterol, and increased levels of HDL cholesterol, but here the exercise intervention have 
been more than 8 weeks5,34,42. Summarized, it is more likely that blood markers had changed if 
the intervention period had continued for several months, or with increased duration of each 
exercise session5,34,42,82.  
 
Effects on maximal aerobic capacity 
The individuals in both groups had a similar initial VO2max, in the range of 25-35 mL  kg-1  min-1. 
The HIIT group significantly (p<0.01) increased their VO2max during the exercise period, which 
was as anticipated considering previous related studies18,32,34. The benefits of a higher aerobic 
capacity are many, but the managing of daily activities may be the best-perceived effect for these 
elderly men.  All the subjects in the HIIT group increased their VO2max, individually increasing by 
3-28%. These results are comparable to the earlier mentioned studies, which detected a 
increase in VO2max by 10-25% following high-intensity training5,35-37. In a study where eleven 
men (73.5+/-4.2 years) performed 14 weeks of high-intensity interval training on ergometer 
cycle, the subjects improved their VO2max by 18.6% (26.84.4 to 31.85.2 mL  kg-1  min-1, 
p<0.01)85. These results are very similar to our eight weeks study, where the HIIT group 
improved their VO2max with 14.6% (29.44.4 to 33.75.1 mL  kg-1  min-1, p<0.01). Our results 
clearly prove that high-intensity interval training is efficient to increase VO2max in 70-75 year old 
men. From being almost 14% lower than the general average for men >70 years old, at 35.3 mL  
kg-1  min-1, the HIIT group were able to nearly reach the average24. The individual differences of 
improvement in VO2max seen in participants of the HIIT group might be explained by differences 
in initial VO2max-levels, body composition, or genes5,13,16,18,32,34. A main criterion to improve the 
VO2max is exercise intensity5,17. All participants of the HIIT group were instructed to keep an 
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intensity of 85-95% of HRmax during every exercise session, and were personally followed. 
However, if a participant constantly exercised in the upper level (95%) versus the lower level 
(85%) of the HRmax, this may give individual difference of improvement in VO2max.  
 
The control group did not change their VO2max significantly, but shows great individual 
variations. The subject with the minimum change had a decrease of 7%, whereas the best 
individual improvement was an increase of 12%. The undetermined differences in activity level 
among the controls is most probably the reason for the individual variation of change in VO2max, 
see more in section 4.4. Furthermore, the effects of joining an exercise study, even though you 
are randomized to the control group, may in some situations encourage the participants to 
perform more physical activity as a consequence of the information provided in the participant 
information.  
 
4.3 Epigenetic and genetic effects of high-intensity interval training  
 
Effects on DNA methylation levels 
The aim of this project was to explore if high-intensity interval training could induce changes in 
DNA methylation in skeletal muscle. Whether an up-regulation or down-regulation of DNA 
methylation of genes is positive or not is still unclear. The theory was that sedentary people and 
active people would have opposite effects on the DNA methylation of specific genes, whereas 
some genes would also remain unchanged. It is known that DNA methylation increases with 
age44,55. If exercise were able to modulate DNA methylation, the theory suggests that it would 
also be capable of suppressing the natural changes of DNA methylation caused by age. These 
theories are supported in the article by Nakajima et al., which found that DNA methylation in a 
CpG island of the gene ASC was higher in active elderly people than in sedentary elderly86. This 
study also showed that ASC was expressed differently according to the subjects’ age and physical 
activity86. Furthermore, the DNA methylation level of another gene that the same study analyzed, 
P15, was not affected by either age or exercise86. The same theories were also supported in the 
present project, since we observed that HIIT altered DNA methylation in MYH1, VDAC2, BNIP3, 
and COX16 in the opposite direction of the control group. However, no significance was detected, 
and the lack of validation of the chosen CpG sites makes the inverse relationship insecure. Our 
suggestion is that the observed changes in DNA methylation should have been validated by DNA 
methylation specific PCR, and in a larger population to be confirmed. 
 
 Discussion  
 35 
It is interesting that the most extreme changes in DNA methylation are detected in individuals of 
opposite groups; subject number 4135 in the control group and subject number 3505 in the HIIT 
group (see Appendix I). The control subject showed the maximum individual increase in DNA 
methylation of the CpG sites at MYH1 and VDAC2, and the second highest increase of the CpG site 
at COX16, as well as the utmost decrease in DNA methylation of the CpG site at BNIP3. 
Furthermore, the greatest opposites were found within the HIIT-subject. The interesting part of 
this is that this control subject also had the utmost decrease in VO2max, whereas this HIIT-subject 
had the maximum increase in VO2max. These opposite findings of changes in DNA methylation, 
both between these individuals and the two groups in general, support that an improvement in 
VO2max takes part in suppression of the DNA methylation natural changes. 
 
Effects on gene expression 
A research objective was to explore if a probable change in DNA methylation of a gene could 
inversely affect the genes expression. The article of Nakajima et al. supports this theory where 
they proved that a high amount of DNA methylation (of seven CpG sites in a CpG island near 
exon 1 of the gene ASC) was associated with a lower gene expression in elderly people86. Our 
theory was that these potential changes in DNA methylation and gene expression would be 
associated with exercise in a positive manner. However, it is worth mentioning that whether this 
means more or less gene expression depends on which gene is considered. These theories are 
supported in the article by Timmons et al., which proved that 6-20 weeks of endurance training 
resulted in several variations in how genes were expressed and had a significant effect on how 
fit people became16. This is also supported by the Nakajima study, which found that moderate 
exercise of older subjects might restore the DNA methylation levels in ASC to comparably 
younger levels86. Accordingly, exercise have former been proven to affect DNA methylation and 
gene expression in a positive manner. However, in our study no significant difference in change 
of gene expression was detected between the groups, which support our null hypothesis that no 
exercise-induced changes in gene expression of MYH1, VDAC2, BNIP3, and COX16 occur.  
 
Along with no changes in gene expression, also no significant correlations could be detected for 
the changes in DNA methylation and the changes in gene expression for the genes MYH1, VDAC2, 
BNIP3, and COX16, in either group. In the HIIT group, a detected significant correlation would 
support our research hypothesis and the second research objective. Also, such a detection would 
have been a tool in the confirmation or debunk of the findings of change in DNA methylation 
from the Illumina microarray.  
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4.4 Limitations of the study 
The main concerns of the study are the small study population, the multiple testing problems in 
the statistical analyses of the results from the Illumina microarray, and the lack of a validating 
step of the DNA methylation analysis. Further limitations of the study may be the duration of the 
exercise period, the lack of reports on dietary pattern, and varied exercise habits within the 
control group.  
 
The first limitation of the project is the small number of participants. As mentioned, the numbers 
of participants were considered sufficient at start but with several exclusions, both for the DNA 
methylation analysis and generally during data analyses, the number of participants became 
scarce. The Illumina microarray analysis should optimally have included all the participants; 
however this was limited by economy. In general, with a low number of participants the project 
got limitations regarding statistically significant findings. However, some new theories could 
appear based on the project's findings, which again may give life to new projects. A larger 
number of subjects in the project would have enhanced the statistical power. The data found 
significant should therefore be reproduced in a larger population to potentially have an impact 
on the guidelines of physical activity in this group of elderly people.  
 
A second limitation is the multiple testing problems in the statistical analyses of the Illumina 
microarray, and the lack of a validating step of these results. Dealing with a small number of 
participants, and the detection of 450 000 CpG sites in each sample, made the multiple testing 
problems prominent. Therefore, it always exist a possibility of false positives within the created 
“Ranged list”. This makes the results from the Illumina microarray not strong enough to give 
reliable results about DNA methylation levels alone. Hence, a validating step of the detected 
changes in DNA methylation levels should have been included, and may have been performed by 
DNA methylation specific PCR on the chosen specific CpG sites. DNA methylation specific PCR 
analyses were meant to be performed in this present project, but due to the lack of commercial 
available kits for this purpose, and limited amount of time to develop a custom-made procedure, 
this were not done. With no validation, the choice of CpG sites from the “Ranged list” was only 
based on a literature search. Optimally, as many as possible of the CpG sites from the “Ranged 
list” should have been investigated by DNA methylation specific PCR. Then, the associated genes 
of the validated CpG sites could have been further examined by gene expression specific PCR.  
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Further limitations may be the duration of the exercise period. Exercise is known to have 
positive health effects when performed regularly, thus a longer exercise period may have 
increased the possibilities of exploring positive health effects. Also, the lack of information on 
participants’ dietary habits, smoking habits, alcohol consumption, as well as more detailed 
information about medical use may also be a limitation; because coffee, alcohol and smoking are 
possible affecters of DNA methylation44,45,63. Finally, the activity levels in the control group may 
be a limitation for the study. The project includes controls intended to behave as normally, and 
not change their dietary pattern or exercise habits. Hence, there may be great variability in 
exercise habits among the controls. The theory was that the intervened change in exercise would 
be the possibility of finding differences between the groups. However, to be able to explore 
possible changes in DNA methylation and gene expression it may have been better to include a 
sedentary control group, and therefore rather analyze the extremes. Then, the results (if 
significant) could explain the outcomes of an active lifestyle versus an inactive one.  
 
4.5 Future directions  
First, as briefly done in the present project but with alternative directions; the results from the 
Illumina Infinium HumanMethylation450 BeadChip can be analyzed following multiple 
procedures, where alternative perspectives and inputs can be used to produce multiple “Ranged 
lists” from the same Illumina microarray results. First, one alternative way of searching for 
candidate CpG sites is to look for multiple CpG sites that are related to the same gene in the top of 
the “Ranged list”. This may lead to a great chance of finding a correlation between change in 
DNA methylation and regulation of gene expression. A second alternative is to make several 
“Ranged list” by different inputs and perspectives, and then chose the CpG sites that are present 
in several lists for further analyses. A third alternative is to make a new general group (consisting 
of the originally control group at baseline and follow-up, and the originally HIIT group at 
baseline), and make a “Ranged list” by comparing this new group to the originally HIIT group at 
follow-up. Then, the assumptions would be that the control subjects and the HIIT-subjects were 
similar at start, and that no changes occurred in the control group during the exercise period. 
This third alternative may be a good alternative to reveal only the CpG sites that actually 
changed because of the exercise. Generally for all three alternatives, whichever CpG sites are 
chosen they should all be validated by DNA methylation specific PCR in an expanded number of 
subjects. Thereafter, gene expression specific PCR should be performed on the respective genes 
to explore whether the change in DNA methylation affected the expression of the genes.  
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Then, considering other future directions of epigenetics in general, possibilities seem enormous. 
DNA methylation of CpG sites and genes should be thoroughly investigated. In the future the 
status of DNA methylation may increase the molecular understanding of different diseases. 
Maybe disease-associated genes can be detected and exercise can be introduced as a preventive 
or treating intervention for these diseases. Or maybe disease-associated pathways that are 
triggered by epigenetic changes can be detected, and these pathways can be introduced as drug 
targets for the pharmacological industry. Surely, these are just ideas and lots remain to derive 
these theories. 
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5 Conclusion 
Eight weeks of high-intensity interval training of 70-75 year old men was well tolerated, and 
gave significant improvements in maximal aerobic capacity. The HIIT group significantly 
reduced their waist circumference and body mass index, whereas the control group significantly 
decreased their HDL cholesterol. An inverse relationship was detected between the groups 
regarding their change in DNA methylation of four specific CpG sites, but the relationships were 
not proven significant. Furthermore, no significant differences were detected between the 
groups’ changes in gene expression of MYH1, VDAC2, BNIP3, and COX16, which are the genes 
associated with the four specific CpG sites. However, the results give reasons to believe that an 
improvement in VO2max can affect the naturally occurring changes of DNA methylation in our 
genome. Still, larger and more extensive studies are needed to determine whether high-intensity 
interval training actually changes DNA methylation, and to find out which consequences these 
changes have. 
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Appendixes 
 
Appendix A: Informed consent 
All the participants had to approve their participation and sign this written, informed consent 
before their involvement in the study. The information is written in Norwegian. For information 
only, this informed consent also contains some material not included in this report, because it is 
part of another project.  
 
 
Forespørsel om deltakelse i forskningsprosjektet 
”Epigenetiske endringer ved moderat og høy intensiv 
trening” 
 
Studien er godkjent av Regional Komité for Medisinsk og Helsefaglig Forskningsetikk, Midt-
Norge. 
 
Bakgrunn og hensikt 
Dette er et spørsmål til deg om å delta i et underprosjekt til «Generasjon 100». Vi ønsker å 
undersøke om åtte uker med trening kan påvirke genuttrykk i blod og muskelvev, og videre 
om dette eventuelt skyldes epigenetiske endringer målt som DNA-metylering. Vi ønsker å 
undersøke om det er ulik effekt om du trener med moderat versus høy intensitet. Du 
inviteres herved til å delta i denne treningsstudien som gjennomføres ved St. Olavs Hospital 
og NTNU.  
 
Hva innebærer studien? 
Dersom du takker ja til å delta i studien, vil du bli innkalt til pre-testing, deretter gjennomgå 
en åtte ukers treningsperiode ved St. Olavs Hospital, for så å gjøre post-tester. De som deltar i 
studien vil, etter pre-testing (se info lenger ned), bli tilfeldig plassert i en av de tre følgende 
gruppene: kontroll, trening med moderat intensitet, eller trening med høy intensitet. 
Treningsgruppene skal trene tre ganger i uken i åtte uker, på St. Olavs Hospital, hvor en 
treningsveileder vil være tilstede under alle treningene. Kontrollgruppen skal bare fortsette 
med sine daglige aktiviteter, uten å drastisk endre kosthold eller mosjonsvaner. Pre- og post-
testene vil i hovedsak inneholde blodprøvetaking og muskelbiopsi. Se utdypende forklaring 
om hva studien innebærer lenger ned. 
 
Mulige fordeler og ulemper 
Det er svært gode holdepunkter for at regelmessig trening gir bedre helse enn om man ikke 
trener. Ved å delta i prosjektet vil du bidra til viktig forskning, samt få kunnskap om trening, 
fysisk aktivitet og helse. Deltakerne vil få utført en rekke kliniske undersøkelser og 
oppfølging som de ellers ikke ville fått (gjelder også kontrollgruppen). Alle metodene som 
skal benyttes i prosjektet er godt utprøvd tidligere, både på friske mennesker og i ulike 
risikogrupper. De anses derfor ikke for å være risikable eller å ha negative bivirkninger.  
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Ulemper kan likevel være forbigående stølhet i muskler og ledd etter trening, særlig i starten 
hvis du ikke er vant til å trene. Et par dager etter muskelbiopsi, vil man og kunne oppleve 
forbigående muskelømhet (som å ha fått en «lårhøne»). Risikoen for en eventuell infeksjon 
ved inngrepet ansees som liten og forebygges ved bruk av sterile teknikker, samt at prøven 
tas av lege. Inngrepet føres inn i den enkeltes pasientjournal. Skulle det oppstå en infeksjon 
vil dette bli undersøkt og behandlet av lege. Medisinsk ansvarlig for studien er MD Erlend 
Hassel, ISB, NTNU.  
 
Hva skjer med prøvene og informasjonen om deg?  
Hvis du sier ja til å delta i studien, har du alltid rett til å få innsyn i hvilke opplysninger som er 
registrert om deg. Opplysninger og prøver merkes med et løpenummer og behandles uten 
navn, fødselsnummer eller andre opplysninger som gjør at den enkelte pasient kan 
gjenkjennes. En kode knytter deg til dine opplysninger og prøver til en navneliste. 
Navnelisten vil bli slettet i 2020, etter dette kan ingen opplysninger som er lagret, knyttes til 
deg. Dersom du trekker deg fra studien, kan du kreve å få slettet innsamlede prøver og 
opplysninger, med mindre opplysningene allerede er inngått i analyser eller brukt i 
vitenskapelige publikasjoner. Det vil ikke være mulig å identifisere deg i resultatene av 
studien ved en eventuell publikasjon. Alle medarbeidere i studien har taushetsplikt. 
 
Frivillig deltakelse 
Det er frivillig å delta i studien. Du kan når som helst trekke ditt samtykke til å delta i studien 
uten å oppgi noen grunn. Dette vil ikke få konsekvenser for din videre behandling, eller 
deltakelse i hovedprosjektet «Generasjon 100». Dersom du ønsker å delta, undertegner du 
samtykkeerklæringen på siste side. Dersom du senere ønsker å trekke deg eller har spørsmål 
til studien, kan du kontakte: 
 
Kine Andenæs på telefon 48008411 (epost: kinean@stud.ntnu.no) 
Ali Shahab på telefon 47661223 (epost: alims@stud.ntnu.no) 
Anja Bye på telefon 92644422 (epost: anja.bye@ntnu.no)   
Dorthe Stensvold på telefon 92092856 (epost: dorthe.stensvold@ntnu.no) 
 
 
Ytterligere informasjon om studien finnes i kapittel A – utdypende forklaring av hva 
studien innebærer. 
Ytterligere informasjon om biobank, personvern og forsikring finnes i kapittel B – 
Personvern, biobank, økonomi og forsikring.  
 
Samtykkeerklæring følger etter kapittel B. 
 Appendixes 
 IX 
Kapittel A- utdypende forklaring av hva studien innebærer 
 
Bakgrunn for studien 
Aldring er preget av funksjonelle og fysiologiske endringer og omfatter nedgang i maksimalt 
oksygenopptak, redusert muskelmasse og nedsatt funksjonsevne. I tillegg øker risikoen for 
sykdomsutvikling og forekomsten av både type-2 diabetes, kreft, KOLS, samt psykiske plager 
som depresjon og demens med alderen. I dette studiet ønsker vi å se på DNA-metylering i 
forhold til trening. DNA er menneskets arvemateriale. DNA-metylering er en kjemisk 
modifisering av DNAet som forekommer naturlig i alle levende organismer. Metylering av 
DNA påvirker mange funksjoner i kroppen vår, blant annet hvordan genene reguleres. 
Aldring er en av flere faktorer som påvirker DNA-metyleringen, og eldre mennesker har vist 
seg å ha høyere nivåer av DNA-metylering enn yngre. Økt fysisk aktivitet har en positiv effekt 
på mange av de plager og sykdommer som ofte opptrer hos eldre, men det er fortsatt ikke 
klart om fysisk aktivitet kan påvirke DNA-metylering. Hovedmålet med dette prosjektet er å 
undersøke om åtte uker med utholdenhetstrening kan endre den globale metylering av DNA 
hos eldre, og eventuelt om trening av ulik intensitet påvirker DNA-metyleringen forskjellig. I 
tillegg til å måle global metylering i blod og muskelvev, vil det og kunne bli målt DNA-
metylering av noen spesifikke gener involvert i metabolismen. 
 
Hvem kan delta i studien? 
Vi ønsker å rekruttere 45 friske menn mellom 70-75 år, med BMI på 20-30,og som har 
bostedsadresse i Trondheim kommune. Tidligere studier har vist at DNA-metyleringen hos 
menn og kvinner er forskjellig, derfor ønsker vi bare å inkludere ett kjønn. I hovedprosjektet 
«Generasjon 100» vil alle mellom 70-75 år i Trondheim kommune bli invitert til å delta. Det 
er et tilfeldig utvalg av de som deltar i «Generasjon 100” og som innfrir våre 
inklusjonskriterier, som vil blir forespurt om å delta i dette underprosjektet. 
Eksklusjonskriterier for studien er: kjent hjertesykdom, aktiv kreftsykdom, betydelig 
lungesykdom, ukontrollert hypertensjon, funksjonshemninger som gjør at man ikke kan 
trene, motvilje til å delta i studiet eller å underskrive erklæringsskjemaet, narkotika og/eller 
alkoholmisbruk.   
 
Hvordan foregår studien: 
Deltakerne vil etter inklusjon bli testet og randomisert til enten en treningsgruppe eller en 
kontrollgruppe. Treningsgruppene vil gjennomføre åtte uker med moderat eller høy intensiv 
trening, tre ganger i uken. Treningen vil foregå ved gange/løp på tredemølle, og det vil være 
en treningsveileder tilstede ved hver treningsøkt. Avhengig av hvilken treningsgruppe man 
tilhører er det lagt opp til bestemte treningsprogram. Kontrollgruppa får ikke tilbud om 
veiledet trening og blir bedt om å fortsette sine daglige aktiviteter som før. Etter 
treningsperioden blir det ny testing, for alle gruppene, av de samme parameterne som før 
treningsperioden (disse er nevnt nedenfor). Kontrollgruppa vil få tilbud om en time 
treningsveiledning etter studieslutt.  
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Følgende tester blir gjort før og etter åtte uker med trening:  
 
Maksimal oksygenopptak 
Alle målingene av oksygenopptak foretas under gange på tredemølle. Tredemølleprotokollen 
består av kontinuerlig gange til utmattelse. Hastigheten vil være 4-5 km/t og stigningen på 
mølla starter på 0 % og økes med 2 % for hvert andre minutt. Protokollen gjennomføres til 
deltakeren har nådd sitt maksimale oksygenopptak eller til utmattelse. 
 
Muskelbiopsi 
Det vil bli tatt ut en liten muskelprøve fra lårmuskulaturen før og etter åtte uker med 
trening. Det vil bli gitt lokal bedøvelse før selve inngrepet. Veletablerte prosedyrer fra vår 
forskningsgruppe blir brukt, metoden ansees som forsvarlig og sikker, og blir utført av lege. 
 
Andre tester 
Det vil bli tatt en fastende blodprøve fra venen i armen. I tillegg vil vi måle vekt, blodtrykk, 
hvilepuls og kroppssammensetning. Deltakerne skal også fylle ut et spørreskjema som 
omhandler livskvalitet, aktivitetsnivå og funksjonsnivå (samme spørreskjema som brukt i 
studien «generasjon 100» som er godkjent av REK: 2012/381).   
  
Fordeler ved å delta i studien 
Alle deltagerne får en grundig helseundersøkelse samt opplæring i hvordan man kan trene. I 
tillegg vil man få veiledet trening tre ganger i uken i 8 uker.  
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Kapittel B - Personvern, biobank, økonomi og forsikring 
Personvern 
Opplysninger som registreres om deg er resultatet av alle prøver, spørreskjema og 
oppfølging i forbindelse med treningen. En kode knytter deg til dine opplysninger og prøver 
gjennom en navneliste.  Det er kun 4 autorisert personell knyttet til prosjektet som har 
adgang til navnelisten og som kan finne tilbake til deg. Navnelisten vil slettes i 2020, etter 
dette kan ingen opplysninger som er lagret knyttes til deg. Prosjektlederne Anja Bye (Post-
doc) og Dorthe Stensvold (Post-doc), ved NTNU, er databehandlingsansvarlig. 
Biobank 
Blodprøvene som blir tatt og analyseresultatene vil bli lagret i en allerede opprette biobank 
(G-100). Hvis du sier ja til å delta i studien, gir du også samtykke til at det biologiske 
materialet og analyseresultatene inngår i biobanken. Ulrik Wisløff er ansvarshavende for 
forskningsbiobanken. Dataene i biobanken er avidentifisert, og listen som kobler sammen 
løpenummer og personidentitet vil bli slettet i 2020. I likhet med materiale fra «Generasjon 
100» ønsker vi å oppbevare biologisk materiale og avidentifiserte opplysninger til 2025. Vi 
vil søke REK før nedleggelse av biobank.   
Rett til innsyn og sletting av opplysninger om deg og sletting av prøver  
Du kan når som helst velge å trekke deg fra studien uten å oppgi grunner for dette. Hvis du 
sier ja til å delta i studien, har du rett til innsyn i hvilke opplysninger som er registrert om 
deg. Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. 
Dersom du trekker deg fra studien, kan du kreve å få slettet innsamlede prøver og 
opplysninger, med mindre opplysningene allerede er inngått i analyser eller brukt i 
vitenskapelige publikasjoner.  
Oppfølging 
Etter de planlagte åtte ukene med trening for denne studien skal deltakerne fortsette sin 
deltakelse i «Generasjon 100». For å se på langtidseffektene av trening ønsker «Generasjon 
100» å ta nye biopsier etter ett år og etter tre år, altså ved undersøkelse to og undersøkelse 
tre i «Generasjon 100». Vi minner om at du som deltaker da må gi et nytt samtykke for at en 
ny biopsi skal kunne tas. 
Finansiering 
Studien og biobanken er finansiert gjennom forskningsmidler fra St. Olav Hospital, NTNU og 
Helse Midt-Norge. 
Forsikring 
Pasientene som deltar i studien, er alle dekket mot eventuelle komplikasjoner i Norsk 
pasientskadeerstatning, slik som ved vanlig medisinsk behandling. 
Informasjon om utfallet av studien 
Alle som har deltatt i studien har rett til å få informasjon av resultatet. Det vil sannsynligvis 
være klart mot slutten av 2014. Resultatene vil bli offentliggjort i medisinske tidsskrifter og 
vil trolig også bli omtalt i pressen, men dette vil ta litt tid. Ta gjerne kontakt for informasjon. 
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Samtykke til deltakelse i studien 
 
 
Jeg er villig til å delta i studien  
 
 
---------------------------------------------------------------------------------------------------------------- 
(Signert av prosjektdeltaker, dato) 
 
 
 
 
Jeg bekrefter å ha gitt informasjon om studien 
 
 
---------------------------------------------------------------------------------------------------------------- 
(Signert, rolle i studien, dato) 
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Appendix B: Details of the selected CpG sites 
 
Table B: Details of the selected four CpG sites from the “Ranged list”. 
CpG site (Illumina ID) Cg16842280 Cg26801646 Cg08079580 Cg23562388 
Associated gene name MYH1 VDAC2 BNIP3 COX16 
NCBI Reference Sequence NM_005963.3 NM_003375.3 NM_004052.2 NM_016468.6 
HGVS name 
NC_000017.10:g.1
0422189 
NC_000010.10:g.7
6970496 
NC_000010.10:g.1
33795885 
NC_000014.8:g.70
826455 
Associated TSS * TSS1500 TSS200 TSS1500 TSS200 
Associated to CpG island Yes Yes Yes Yes 
Position on “Ranged list” 15 6 218 279 
Mean DNA methylation 
ratio in control group 
(follow-up/baseline) 
1.233745244 1.316470055 0.899568165 1.125208116 
Mean DNA methylation 
ratio in HIIT group 
(follow-up/baseline) 
0.8649630 0.8570032 1.2565574 0.8504299 
Why our interest: Because 
its translated protein is 
part of… 
Skeleton muscle 
contraction 
Mitochondrial 
membrane 
Mitochondrial 
membrane 
Mitochondrial 
membrane 
*: The number represents the CpG sites position in number of nucleotides from the transcription starting site (TSS); 
NCBI: The National Center for Biotechnology Information; HGVS: Human genome variation society; MYH1: Myosin 
Heavy Chain 1; VDAC2: voltage-dependent anion channel 2; BNIP3: BCL2/adenovirus E1B 19kDa interacting protein 
3; COX16: Cytochrome C Oxidase Assembly Homolog; HIIT: High-intensity interval training. 
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Appendix C: Measured RNA concentrations and dilution details 
 
Table C.1: Measured RNA concentration and dilution details for the control group. 
Control group Measured RNA 
concentration 
at NanoDrop 
(ng/μL) 
Amount of 
RNA (μL) 
Amount of 
RNase free 
water (μL) 
Total volume  
(μL) 
Final 
concentration 
of RNA (ng) Subject number 
  
Baseline 
          
  182 123 9.00 16.45 18.45 90 
  2141 156 7.00 16.04 17.54 90 
  2574 84 13.00 15.90 18.90 90 
  2875 127 9.00 17.10 19.10 90 
  3879 172 7.00 17.79 19.29 90 
  4057 64 15.00 13.30 16.80 90 
  4086 234 5.00 16.51 17.51 90 
  4135 82 13.00 15.47 18.47 90 
  4595 105 11.00 17.19 19.69 90 
  
Follow-up 
       182 338 5.00 24.35 25.35 90 
  2141 324 5.00 23.29 24.29 90 
  2574 74 13.00 13.56 16.56 90 
  2875 59 17.00 13.55 17.55 90 
  3481 211 7.00 22.27 23.77 90 
  3879 179 7.00 18.65 20.15 90 
  4057 93 11.00 14.96 17.46 90 
  4086 212 7.00 22.29 23.79 90 
  4135 238 5.00 16.83 17.83 90 
  4595 126 9.00 16.95 18.95 90 
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Table C.2: Measured RNA concentration and dilution details for the high-intensity interval training (HIIT) 
group. 
HIIT Group Measured RNA 
concentration 
at NanoDrop 
(ng/μL) 
Amount of 
RNA (μL) 
Amount of 
RNase free 
water (μL) 
Total volume  
(μL) 
Final 
concentration 
of RNA (ng) Subject number 
  
Baseline           
  969 130 9.00 17.49 19.49 90 
  1085 139 9.00 18.84 20.84 90 
  2049 248 5.00 17.60 18.60 90 
  2170 175 7.00 18.18 19.68 90 
  2445 76 15.00 16.48 19.98 90 
  3505 124 9.00 16.53 18.53 90 
  3615 145 9.00 19.71 21.71 90 
  3651 159 7.00 16.43 17.93 90 
  3853 59 17.00 13.79 17.79 90 
  4776 73 15.00 15.61 19.11 90 
  
Follow-up 
       969 223 7.00 23.55 25.05 90 
  1085 120 9.00 15.94 17.94 90 
  2049 167 7.00 17.31 18.81 90 
  2170 97 11.00 15.67 18.17 90 
  2445 106 11.00 17.41 19.91 90 
  3505 168 7.00 17.43 18.93 90 
  3615 47 21.00 12.74 17.74 90 
  3651 100 11.00 16.29 18.79 90 
  3853 148 9.00 20.22 22.22 90 
  4776 57 19.00 14.57 19.07 90 
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Appendix D: Set-up for real-time qRT-PCR 
 
Step 1: DNA polymerase activating step 
Step 2: Denaturation 
Step 3: Annealing 
Step 4: Extension 
 
Figure D.1: Temperature and duration (minutes) of the four PCR-steps, where step 3 and 4 are repeated 
44 times. 
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Figure D.2: 96-well plate with information of the contents in each well (numbered 1-12 and A-H). NTC: 
No template control; NRT: No-reverse transcriptase control; C1-C9: Control subject 1-9; H1-H9: Exercise 
subject 1-9; Pre: Baseline sample; Post: Follow-up sample.  
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Appendix E: REC approval  
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Appendix F: Individual changes in weight, body mass index, waist 
circumference and body fat percentage 
 
Table F.1: Individual data on weight and body mass index for both groups at baseline, follow-up, and 
delta values (follow-up/baseline). 
Subject 
number 
Group 
Weight  
(kg) 
BMI  
(kg/m2) 
Baseline Follow-up Delta Baseline Follow-up Delta 
182 Control 87.1 88.0 1.01 27.5 27.9 1.01 
2141 Control 86.0 86.1 1.00 26.3 26.3 1.00 
2574 Control 89.3 88.2 0.99 28.8 28.6 0.99 
2875 Control 95.6 95.8 1.00 28.5 28.8 1.01 
3481 Control 71.4 69.3 0.97 26.2 25.6 0.98 
3879 Control 65.7 65.5 1.00 21.5 21.6 1.00 
4057 Control 91.2 89.9 0.99 26.9 27.0 1.00 
4086 Control 83.5 85.0 1.02 26.7 27.0 1.01 
4135 Control 100.9 99.4 0.99 28.2 28.3 1.00 
4595 Control 65.3 64.6 0.99 24.0 23.8 0.99 
969 HIIT 82.9 80.1 0.97 29.4 28.7 0.98 
1085 HIIT 103.2 100.1 0.97 34.5 33.6 0.97 
2049 HIIT 79.9 78.0 0.98 24.7 24.2 0.98 
2170 HIIT 92.0 90.9 0.99 34.2 34.4 1.01 
2445 HIIT 86.1 84.2 0.98 27.2 26.7 0.98 
3505 HIIT 78.0 75.1 0.96 26.4 25.6 0.97 
3615 HIIT 81.0 80.6 1.00 28.0 28.1 1.00 
3651 HIIT 114.9 108.5 0.94 32.9 31.2 0.95 
3853 HIIT 72.5 72.3 1.00 23.7 23.5 0.99 
4776 HIIT 95.5 94.2 0.99 28.2 28.0 0.99 
BMI: Body mass index; HIIT: High-intensity interval training. 
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Table F.2: Individual data on waist circumference and body fat percentage for both groups, at baseline, 
follow-up, and delta values (follow-up/baseline). 
Subject 
number 
Group 
Waist circumference  
(cm) 
Body fat percentage  
(%) 
Baseline Follow-up Delta Baseline Follow-up Delta 
182 Control 105.5 103.0 0.98 20.0 21.4 1.06 
2141 Control 101.0 102.5 1.01 24.0 24.1 1.00 
2574 Control 107.5 106.5 0.99 32.3 32.0 0.99 
2875 Control 109.0 106.5 0.98 23.9 24.5 1.03 
3481 Control 91.5 85.0 0.93 28.1 28.9 1.03 
3879 Control 92.5 90.5 0.98 19.0 20.2 1.06 
4057 Control 102.5 99.0 0.97 27.2 29.8 1.10 
4086 Control 101.5 101.0 1.00 28.7 26.3 0.92 
4135 Control 105.0 103.0 0.98 27.4 27.3 1.00 
4595 Control 87.0 80.5 0.93 27.1 25.0 0.92 
969 HIIT 108.0 97.5 0.90 32.8 32.0 0.98 
1085 HIIT 116.5 111.0 0.95 42.8 41.8 0.98 
2049 HIIT 92.0 90.0 0.98 23.0 21.3 0.93 
2170 HIIT 112.0 106.5 0.95 36.9 37.1 1.01 
2445 HIIT 100.5 98.0 0.98 25.5 24.8 0.97 
3505 HIIT 90.0 87.0 0.97 24.8 23.3 0.94 
3615 HIIT 103.0 97.0 0.94 31.6 32.2 1.02 
3651 HIIT 119.0 105.0 0.88 33.5 32.1 0.96 
3853 HIIT 90.0 87.0 0.97 20.6 21.3 1.03 
4776 HIIT 106.0 100.0 0.94 26.4 26.4 1.00 
HIIT: High-intensity interval training. 
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Appendix G: Individual changes in circulating blood markers of 
cardiovascular health 
 
Table G.1: Individual data on total cholesterol and LDL cholesterol for both groups at baseline, follow-up, 
and delta values (follow-up/baseline). 
Subject 
number 
Group 
Total cholesterol  
(mmol/L) 
LDL cholesterol 
(mmol/L) 
Baseline Follow-up Delta Baseline Follow-up Delta 
182 Control 6.80 7.60 1.12 5.19 5.92 1.14 
2141 Control 5.30 5.90 1.11 2.43 3.36 1.38 
2574 Control 4.60 6.10 1.33 2.29 3.84 1.68 
2875 Control 6.10 6.10 1.00 4.19 4.32 1.03 
3481 Control 6.80 7.60 1.12 3.85 4.66 1.21 
3879 Control 4.40 3.70 0.84 2.30 1.94 0.84 
4057 Control 6.50 6.60 1.02 4.43 4.73 1.07 
4086 Control 5.90 5.10 0.86 3.40 2.93 0.86 
4135 Control 7.20 7.00 0.97 5.33 5.35 1.00 
4595 Control 3.70 3.60 0.97 1.87 1.91 1.02 
969 HIIT 5.00 5.10 1.02 3.22 3.29 1.02 
1085 HIIT 7.50 7.50 1.00 4.84 5.13 1.06 
2049 HIIT 5.50 5.10 0.93 3.53 3.24 0.92 
2170 HIIT 5.30 5.20 0.98 3.31 3.19 0.96 
2445 HIIT 5.60 5.60 1.00 3.60 3.73 1.04 
3505 HIIT 5.40 5.10 0.94 2.35 2.07 0.88 
3615 HIIT 5.30 5.50 1.04 3.17 3.54 1.12 
3651 HIIT 5.00 4.50 0.90 3.22 2.90 0.90 
3853 HIIT 5.70 5.90 1.04 3.72 4.02 1.08 
4776 HIIT 4.70 5.10 1.09 3.08 3.46 1.12 
LDL: Low-density lipoprotein; HIIT: High-intensity interval training. 
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Table G.2: Individual data on HDL cholesterol and triglycerides for both groups at baseline, follow-up, and 
delta values (follow-up/baseline). 
Subject 
number 
Group 
HDL cholesterol  
(mmol/L) 
Triglycerides  
(mmol/L) 
Baseline Follow-up Delta Baseline Follow-up Delta 
182 Control 1.16 1.14 0.98 0.99 1.21 1.22 
2141 Control 2.49 2.18 0.88 0.85 0.81 0.95 
2574 Control 1.83 1.73 0.95 1.07 1.18 1.10 
2875 Control 1.28 1.27 0.99 1.39 1.14 0.82 
3481 Control 2.57 2.54 0.99 0.85 0.88 1.04 
3879 Control 1.37 1.31 0.96 1.62 1.00 0.62 
4057 Control 1.51 1.30 0.86 1.24 1.26 1.02 
4086 Control 2.14 1.79 0.84 0.80 0.84 1.05 
4135 Control 1.36 1.22 0.90 1.14 0.95 0.83 
4595 Control 1.41 1.26 0.89 0.94 0.95 1.01 
969 HIIT 1.15 1.19 1.03 1.40 1.38 0.99 
1085 HIIT 2.30 1.99 0.87 0.80 0.85 1.06 
2049 HIIT 1.63 1.53 0.94 0.76 0.74 0.97 
2170 HIIT 1.66 1.66 1.00 0.74 0.77 1.04 
2445 HIIT 1.52 1.33 0.88 1.06 1.21 1.14 
3505 HIIT 2.60 2.76 1.06 0.99 0.61 0.62 
3615 HIIT 1.24 1.27 1.02 1.98 1.53 0.77 
3651 HIIT 1.10 1.14 1.04 1.51 1.02 0.68 
3853 HIIT 1.54 1.54 1.00 0.98 0.75 0.77 
4776 HIIT 1.04 1.05 1.01 1.28 1.30 1.02 
HDL: High-density lipoprotein; HIIT: High-intensity interval training. 
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Table G.3: Individual data on glucose and hs-CRP for both groups at baseline, follow-up, and delta values 
(follow-up/baseline). By a mistake hs-CRP was not detected in the blood sample of subject number 3615 
at follow-up, and thus this cell and the respective delta cell are empty. 
Subject 
number 
Group 
Glucose  
(mmol/L) 
Hs-CRP  
(mg/L) 
Baseline Follow-up Delta Baseline Follow-up Delta 
182 Control 5.30 5.10 0.96 1.71 1.76 1.03 
2141 Control 5.70 5.30 0.93 2.09 1.39 0.67 
2574 Control 7.40 6.80 0.92 2.54 2.31 0.91 
2875 Control 6.00 6.10 1.02 1.25 2.13 1.70 
3481 Control 5.20 5.00 0.96 9.19 7.74 0.84 
3879 Control 5.50 5.40 0.98 2.24 1.69 0.75 
4057 Control 8.60 10.10 1.17 2.11 3.00 1.42 
4086 Control 5.40 5.80 1.07 1.09 1.73 1.59 
4135 Control 5.00 5.60 1.12 1.98 2.52 1.27 
4595 Control 4.90 5.40 1.10 0.48 0.40 0.83 
969 HIIT 5.90 6.20 1.05 1.04 1.28 1.23 
1085 HIIT 6.40 6.10 0.95 33.81 3.84 0.11 
2049 HIIT 5.10 4.90 0.96 2.45 2.21 0.90 
2170 HIIT 5.90 6.20 1.05 2.57 1.68 0.65 
2445 HIIT 5.10 5.30 1.04 1.56 2.22 1.42 
3505 HIIT 6.10 7.40 1.21 0.51 1.06 2.08 
3615 HIIT 6.30 6.50 1.03 0.92 - - 
3651 HIIT 5.90 5.20 0.88 0.71 0.89 1.25 
3853 HIIT 5.80 4.50 0.78 0.62 0.46 0.74 
4776 HIIT 6.40 5.90 0.92 2.78 1.40 0.50 
Hs-CRP: High-sensitivity C-reactive protein; HIIT: High-intensity interval training. 
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Appendix H: Individual changes in maximal aerobic capacity  
 
Table H: Individual data on maximal aerobic capacity for both groups at baseline, follow-up, and delta 
values (follow-up/baseline). 
Subject 
number 
Group 
VO2max  
(mL  kg-1  min-1) 
Baseline Follow-up Delta 
182 Control 35.0 33.7 0.96 
2141 Control 28.0 31.3 1.12 
2574 Control 25.4 27.3 1.07 
2875 Control 37.0 40.0 1.08 
3481 Control 37.0 41.0 1.11 
3879 Control 34.0 33.5 0.99 
4057 Control 25.5 26.9 1.05 
4086 Control 37.5 37.5 1.00 
4135 Control 30.5 28.4 0.93 
4595 Control 26.0 26.3 1.01 
969 HIIT 30.0 36.8 1.23 
1085 HIIT 27.0 31.4 1.16 
2049 HIIT 30.0 36.0 1.20 
2170 HIIT 23.0 27.3 1.19 
2445 HIIT 37.0 38.2 1.03 
3505 HIIT 33.0 42.3 1.28 
3615 HIIT 28.0 32.2 1.15 
3651 HIIT 24.5 27.0 1.10 
3853 HIIT 34.5 36.8 1.07 
4776 HIIT 27.0 29.0 1.07 
VO2max: maximal aerobic capacity; HIIT: High-intensity interval training.  
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Appendix I: Individual changes in DNA methylation 
 
Table I.1: Individual data on DNA methylation of CpG site in the promoter region of the associated genes 
MYH1 and VDAC2, for both groups at baseline, follow-up, and delta values (follow-up/baseline). Empty 
cells means the subject was not included in the analysis. 
Subject 
number 
Group 
DNA methylation MYH1 
(Beta values) 
DNA methylation VDAC2 
(Beta values) 
Baseline Follow-up Delta Baseline Follow-up Delta 
182 Control 0.301587 0.376211 1.25 0.097700 0.108197 1.11 
2141 Control - - - - - - 
2574 Control - - - - - - 
2875 Control - - - - - - 
3481 Control - - - - - - 
3879 Control - - - - - - 
4057 Control - - - - - - 
4086 Control - - - - - - 
4135 Control 0.319541 0.446094 1.40 0.060906 0.099101 1.63 
4595 Control 0.306837 0.324557 1.06 0.070816 0.086031 1.21 
969 HIIT 0.311132 0.246104 0.79 0.084283 0.066202 0.79 
1085 HIIT 0.369342 0.321640 0.87 0.090983 0.077543 0.85 
2049 HIIT 0.384279 0.285639 0.74 0.073180 0.073852 1.01 
2170 HIIT 0.310213 0.350430 1.13 0.087684 0.073898 0.84 
2445 HIIT - - - - - - 
3505 HIIT 0.324660 0.236960 0.73 0.136645 0.088837 0.65 
3615 HIIT 0.315300 0.291687 0.93 0.083402 0.083583 1.00 
3651 HIIT - - - - - - 
3853 HIIT - - - - - - 
4776 HIIT - - - - - - 
MYH1: Myosin Heavy Chain 1; VDAC2: voltage-dependent anion channel 2; HIIT: High-intensity interval training. 
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Table I.2: Individual data on DNA methylation of CpG site in the promoter region of the associated genes 
BNIP3 and COX16, for both groups at baseline, follow-up and delta values (follow-up/baseline). Empty 
cells means the subject was not included in the analysis. 
Subject 
number 
Group 
DNA methylation BNIP3 
(Beta values) 
DNA methylation COX16 
(Beta values) 
Baseline Follow-up Delta Baseline Follow-up Delta 
182 Control 0.035173 0.034621 0.98 0.078243 0.084121 1.08 
2141 Control - - - - - - 
2574 Control - - - - - - 
2875 Control - - - - - - 
3481 Control - - - - - - 
3879 Control - - - - - - 
4057 Control - - - - - - 
4086 Control - - - - - - 
4135 Control 0.041227 0.035797 0.87 0.057603 0.064672 1.12 
4595 Control 0.047426 0.040128 0.85 0.065881 0.077593 1.18 
969 HIIT 0.038877 0.046719 1.20 0.067692 0.050114 0.74 
1085 HIIT 0.031149 0.040451 1.30 0.057637 0.053950 0.94 
2049 HIIT 0.031863 0.041107 1.29 0.059835 0.052250 0.87 
2170 HIIT 0.038658 0.043651 1.13 0.072642 0.059845 0.82 
2445 HIIT - - - - - - 
3505 HIIT 0.025801 0.039130 1.52 0.208823 0.134941 0.65 
3615 HIIT 0.034279 0.037814 1.10 0.045588 0.049370 1.08 
3651 HIIT - - - - - - 
3853 HIIT - - - - - - 
4776 HIIT - - - - - - 
BNIP3: BCL2/adenovirus E1B 19kDa interacting protein 3; COX16: Cytochrome C Oxidase Assembly Homolog; HIIT: 
High-intensity interval training.  
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Appendix J: Individual changes of gene expression 
 
Table J.1: Individual data on gene expression of MYH1 and VDAC2, for both groups at baseline, follow-up, 
and delta values (follow-up/baseline). Empty cells means the subject was excluded from the data analyses. 
Subject 
number 
Group 
Gene expression MYH1 Gene expression VDAC2 
Baseline 
(ΔCt) 
Follow-up 
(ΔCt) 
Delta  
(2-ΔΔCt) 
Baseline 
(ΔCt) 
Follow-up 
(ΔCt) 
Delta  
(2-ΔΔCt) 
182 Control 0.571141 -0.234525 1.75 5.018883 4.745515 1.21 
2141 Control 2.373681 0.724295 3.14 4.399667 4.714605 0.80 
2574 Control - - - 5.074679 4.499753 1.49 
2875 Control 3.448027 -0.068182 11.44 4.288813 4.930594 0.64 
3481 Control - - - - - - 
3879 Control -0.707098 -1.263126 1.47 5.467263 5.295227 1.13 
4057 Control 0.331089 -1.163683 2.82 5.201937 5.712226 0.70 
4086 Control 1.775380 1.307970 1.38 4.922813 4.978713 0.96 
4135 Control -0.234469 0.219265 0.73 4.749615 4.490690 1.20 
4595 Control 1.416239 -0.316416 3.32 4.440838 4.757796 0.80 
969 HIIT -0.690777 0.693191 0.38 4.943945 4.678077 1.20 
1085 HIIT 0.075539 0.443740 0.77 4.946180 5.102590 0.90 
2049 HIIT 1.624573 0.919883 1.63 4.410948 4.837720 0.74 
2170 HIIT -0.352780 -1.390774 2.05 4.704365 4.679816 1.02 
2445 HIIT 1.313972 -0.479176 3.47 4.425322 4.769386 0.79 
3505 HIIT 1.154427 0.585278 1.48 4.885610 4.484857 1.32 
3615 HIIT 0.538679 0.037079 1.42 5.598107 5.414517 1.14 
3651 HIIT - - - - - - 
3853 HIIT 0.409417 1.237056 0.56 5.088331 4.910000 1.13 
4776 HIIT - - - 4.494548 4.360000 1.10 
MYH1: Myosin Heavy Chain 1; VDAC2: voltage-dependent anion channel 2; HIIT: High-intensity interval training; Ct: 
cycle threshold. 
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Table J.2: Individual data on gene expression of BNIP3 and COX16, for both groups at baseline, follow-up, 
and delta values (follow-up/baseline). Empty cells means the subject was excluded from the data analyses. 
Subject 
number 
Group 
Gene expression BNIP3 Gene expression COX16 
Baseline 
(ΔCt) 
Follow-up 
(ΔCt) 
Delta  
(2-ΔΔCt) 
Baseline 
(ΔCt) 
Follow-up 
(ΔCt) 
Delta  
(2-ΔΔCt) 
182 Control 8.142539 7.813787 1.26 6.095964 6.184691 0.94 
2141 Control 6.554335 7.467028 0.53 5.136140 6.040526 0.53 
2574 Control - - - 5.653051 5.283407 1.29 
2875 Control 6.857820 7.304058 0.73 5.406255 6.030156 0.65 
3481 Control - - - - - - 
3879 Control 8.243578 8.164110 1.06 6.760049 6.035310 1.65 
4057 Control 7.105399 8.084176 0.51 5.517188 6.359217 0.56 
4086 Control 7.449079 7.336849 1.08 6.016058 6.167627 0.90 
4135 Control 6.946155 6.946378 1.00 5.698213 5.736199 0.97 
4595 Control 6.321473 7.011842 0.62 5.434199 6.009006 0.67 
969 HIIT 7.058693 7.323145 0.83 5.555350 5.826860 0.83 
1085 HIIT 6.781217 6.985312 0.87 5.814319 6.146984 0.79 
2049 HIIT 6.391804 7.335266 0.52 5.376178 5.985891 0.66 
2170 HIIT 6.487051 6.782428 0.81 5.623651 5.690485 0.95 
2445 HIIT 6.789155 7.118723 0.80 5.352601 5.673736 0.80 
3505 HIIT 7.466215 7.121903 1.27 5.804218 5.784298 1.01 
3615 HIIT 8.806499 7.670701 2.20 6.695814 6.273776 1.34 
3651 HIIT 7.156362 7.819605 0.63 5.903714 6.165746 0.83 
3853 HIIT 7.877529 7.219458 1.58 6.070505 5.937033 1.10 
4776 HIIT - - - 5.310185 4.360000 1.93 
BNIP3: BCL2/adenovirus E1B 19kDa interacting protein 3; COX16: Cytochrome C Oxidase Assembly Homolog; HIIT: 
High-intensity interval training; Ct: cycle threshold. 
 
